The present invention relates generally to systems and methods for improved electrochemical measurement of analytes. The preferred embodiments employ electrode systems including an analyte-measuring electrode for measuring the analyte or the product of an enzyme reaction with the analyte and an auxiliary electrode configured to generate oxygen and/or reduce electrochemical interferants. Oxygen generation by the auxiliary electrode advantageously improves oxygen availability to the enzyme and/or counter electrode; thereby enabling the electrochemical sensors of the preferred embodiments to function even during ischemic conditions. Interferant modification by the auxiliary electrode advantageously renders them substantially non-reactive at the analyte-measuring electrode, thereby reducing or eliminating inaccuracies in the analyte signal due to electrochemical interferants.
|
0. 98. An electrochemical sensor for measuring a concentration of an analyte in a biological fluid in a host, the sensor comprising:
a membrane system comprising: a cell impermeable domain configured to contact a biological fluid in a host and an enzyme domain comprising enzyme, wherein the enzyme reacts with the analyte;
a working electrode comprising a conductive material and configured to measure a product of the reaction of the enzyme with the analyte; and
an auxiliary electrode located within or adjacent to the membrane system and comprising a conductive material and configured to modify an electrochemical interferent such that the electrochemical interferent is rendered substantially electrochemically non-reactive at the working electrode.
0. 116. An electrochemical sensor for continuous measurement of a concentration of an analyte in an in vivo biological environment, the sensor comprising:
a membrane comprising an outermost layer configured for protection of the sensor from the biological environment, wherein the membrane further comprises an enzyme configured to react with the analyte;
a working electrode comprising a conductive material and configured to measure a product of the reaction of the enzyme with the analyte; and
an auxiliary electrode located within or adjacent to the membrane and comprising a conductive material, wherein the auxiliary electrode is configured to modify an electrochemical interferent such that the electrochemical interferent is rendered substantially electrochemically non-reactive at the working electrode.
1. An electrochemical sensor for determining a presence or a concentration of an analyte in a fluid, the sensor comprising:
a membrane system comprising an enzyme, wherein the enzyme reacts with the analyte;
an electroactive surface comprising a working electrode, the working electrode comprising a conductive material and configured to measure a product of the reaction of the enzyme with the analyte; and
an auxiliary electrode comprising a conductive material and configured to generate oxygen, wherein the auxiliary electrode is situated such that the oxygen generated diffuses to the enzyme or to the electroactive surface, wherein the auxiliary electrode comprises a polymer, wherein the polymer is situated on a surface of the auxiliary electrode, and wherein the polymer comprises a material that is directly impermeable to glucose but is permeable to oxygen.
25. An electrochemical sensor for determining a presence or a concentration of an analyte in a fluid, the sensor comprising:
a membrane system comprising an enzyme, wherein the enzyme reacts with the analyte;
an electroactive surface comprising a working electrode, the working electrode comprising a conductive material and configured to measure a product of the reaction of the enzyme with the analyte; and
an auxiliary electrode comprising a conductive material and configured to modify an electrochemical interferant interferent such that the electrochemical interferent is rendered substantially electrochemically non-reactive at the working electrode, wherein the auxiliary electrode comprises a polymer, wherein the polymer is situated on a surface of the auxiliary electrode, and wherein the polymer comprises a material that is impermeable to glucose but is permeable to oxygen.
13. An electrochemical sensor for determining a presence or a concentration of an analyte in a fluid, the sensor comprising:
a membrane system comprising an enzyme, wherein the enzyme reacts with the analyte;
an electroactive surface comprising a working electrode, the working electrode comprising a conductive material and configured to measure a product of the reaction of the enzyme with the analyte; and
an auxiliary electrode comprising a conductive material and configured to generate oxygen, wherein the auxiliary electrode is situated such that the oxygen generated diffuses to the enzyme or to the electroactive surface, wherein the auxiliary electrode comprises a polymer, wherein the polymer is directly situated on a surface of the auxiliary electrode, and wherein the polymer comprises a material that is impermeable to glucose but is permeable to oxygen and permeable to interfering species.
39. An electrochemical sensor for determining a presence or a concentration of an analyte in a fluid, the sensor comprising:
a membrane system comprising an enzyme, wherein the enzyme reacts with the analyte;
an electroactive surface comprising a working electrode, the working electrode comprising a conductive material and configured to measure a product of the reaction of the enzyme with the analyte; and
an auxiliary electrode comprising a conductive material and configured to modify an electrochemical interferant interferent such that the electrochemical interferent is rendered substantially electrochemically non-reactive at the working electrode, wherein the auxiliary electrode comprises a polymer, wherein the polymer is situated on a surface of the auxiliary electrode, and wherein the polymer comprises a material having a molecular weight that blocks glucose and allows transport therethrough of oxygen, urate, ascorbate, and acetaminophen.
0. 72. An electrochemical sensor for determining a presence or a concentration of an analyte in a fluid, the sensor comprising:
a membrane system comprising an enzyme configured to react with the analyte;
an electroactive surface comprising a working electrode, the working electrode comprising a conductive material and configured to measure a product of the reaction of the enzyme with the analyte; and
an auxiliary electrode comprising a conductive material and configured to modify an electrochemical interferent such that the electrochemical interferent is rendered substantially electrochemically non-reactive at the working electrode, wherein the auxiliary electrode comprises a polymer, wherein the polymer is situated on a surface of the auxiliary electrode such that at least a portion of the polymer is located more distal to the electroactive surface than the auxiliary electrode, and wherein the polymer comprises a material that is permeable or impermeable to glucose but is permeable to oxygen.
0. 60. An electrochemical sensor for measuring a concentration of an analyte in a biological fluid, the sensor comprising:
a membrane system comprising an enzyme configured to react with the analyte;
an electroactive surface comprising a working electrode, the working electrode comprising a conductive material and configured to measure a product of the reaction of the enzyme with the analyte; and
an auxiliary electrode comprising a conductive material and configured to generate oxygen, wherein the auxiliary electrode is situated at a location directly between the electroactive surface and the biological fluid being measured such that the oxygen generated diffuses to the enzyme or to the electroactive surface, wherein the auxiliary electrode comprises a polymer, wherein the polymer is directly situated on a surface of the auxiliary electrode, and wherein the polymer comprises a material that is permeable or impermeable to glucose but is permeable to oxygen and permeable to one or more interfering species.
0. 86. An electrochemical sensor for determining a presence or a concentration of an analyte in a fluid, the sensor comprising:
a membrane system comprising an enzyme configured to react with the analyte;
an electroactive surface comprising a working electrode, the working electrode comprising a conductive material and configured to measure a product of the reaction of the enzyme with the analyte; and
an auxiliary electrode comprising a conductive material and configured to modify an electrochemical interferent such that the electrochemical interferent is rendered substantially electrochemically non-reactive at the working electrode, wherein the auxiliary electrode located within or adjacent to a membrane system such that at least a portion of the membrane system is located more distal to the electroactive surface than the auxiliary electrode, and wherein the membrane system comprises a polymer comprising a material having a molecular weight that allows transport therethrough of oxygen, urate, ascorbate, and acetaminophen.
0. 51. An electrochemical sensor for measuring a concentration of an analyte in a biological fluid, the sensor comprising:
a membrane system comprising an enzyme configured to react with the analyte;
an electroactive surface comprising a working electrode, the working electrode comprising a conductive material and configured to measure a product of the reaction of the enzyme with the analyte; and
an auxiliary electrode comprising a conductive material and configured to generate oxygen, wherein the auxiliary electrode is situated such that the oxygen generated diffuses to the enzyme or to the electroactive surface, wherein the auxiliary electrode comprises a polymer, wherein the polymer is situated on a surface of the auxiliary electrode, and wherein the polymer comprises a material that is permeable or impermeable to glucose but is permeable to oxygen, and wherein the sensor is configured such that the auxiliary electrode is located between the electroactive surface of the working electrode and the biological fluid being measured.
0. 143. An electrochemical sensor for measuring a concentration of an analyte in a biological fluid, the sensor comprising:
a membrane system comprising an enzyme configured to react with an analyte;
an electroactive surface comprising a working electrode, the working electrode comprising a conductive material and configured to measure a product of a reaction of the enzyme with the analyte; and
an auxiliary electrode comprising a conductive material and configured to generate oxygen, wherein the auxiliary electrode is situated such that the oxygen generated diffuses to the enzyme or to the electroactive surface, wherein the auxiliary electrode comprises a polymer, wherein the polymer is situated on a surface of the auxiliary electrode, wherein the polymer comprises a material that is permeable or impermeable to glucose but is permeable to oxygen, wherein the polymer comprises a material that is permeable to interfering species, and wherein the sensor is configured such that the auxiliary electrode is located between the electroactive surface of the working electrode and a biological fluid in which a concentration of the analyte is being measured.
0. 133. An electrochemical sensor for measuring a concentration of an analyte in a biological fluid, the sensor comprising:
a membrane system comprising an enzyme configured to react with an analyte;
an electroactive surface comprising a working electrode, the working electrode comprising a conductive material and configured to measure a product of a reaction of the enzyme with the analyte; and
an auxiliary electrode comprising a conductive material and configured to generate oxygen, wherein the auxiliary electrode is situated such that the oxygen generated diffuses to the enzyme or to the electroactive surface, wherein the auxiliary electrode comprises a polymer, wherein the polymer is situated on a surface of the auxiliary electrode, wherein the polymer comprises a material that is permeable or impermeable to glucose but is permeable to oxygen, and wherein the sensor is configured such that the auxiliary electrode is located between the electroactive surface of the working electrode and a biological fluid in which a concentration of the analyte is being measured;
wherein the sensor is configured for insertion or implantation into a subcutaneous tissue of a host.
2. The electrochemical sensor of
3. The electrochemical sensor of
4. The electrochemical sensor of
5. The electrochemical sensor of
6. The electrochemical sensor of
7. The electrochemical sensor of
8. The electrochemical sensor of
9. The electrochemical sensor of
10. The electrochemical sensor of
11. The electrochemical sensor of
12. The electrochemical sensor of
14. The electrochemical sensor of
15. The electrochemical sensor of
16. The electrochemical sensor of
17. The electrochemical sensor of
18. The electrochemical sensor of
19. The electrochemical sensor of
20. The electrochemical sensor of
21. The electrochemical sensor of
22. The electrochemical sensor of
23. The electrochemical sensor of
24. The electrochemical sensor of
26. The electrochemical sensor of
27. The electrochemical sensor of
28. The electrochemical sensor of
29. The electrochemical sensor of
30. The electrochemical sensor of
31. The electrochemical sensor of
32. The electrochemical sensor of
33. The electrochemical sensor of
34. The electrochemical sensor of
35. The electrochemical sensor of
36. The electrochemical sensor of
37. The electrochemical sensor of
38. The electrochemical sensor of
40. The electrochemical sensor of
41. The electrochemical sensor of
42. The electrochemical sensor of
43. The electrochemical sensor of
44. The electrochemical sensor of
45. The electrochemical sensor of
46. The electrochemical sensor of
47. The electrochemical sensor of
48. The electrochemical sensor of
49. The electrochemical sensor of
50. The electrochemical sensor of
0. 52. The electrochemical sensor of claim 51, wherein the auxiliary electrode comprises a conductive material selected from the group consisting of a conductive metal, a conductive polymer, and a blend of a conductive metal and a conductive polymer.
0. 53. The electrochemical sensor of claim 51, wherein the auxiliary electrode comprises a form selected from the group consisting of a mesh, a grid, and a plurality of spaced wires.
0. 54. The electrochemical sensor of claim 51, wherein the polymer comprises a material having a molecular weight that allows transport therethrough of oxygen, urate, ascorbate, and acetaminophen.
0. 55. The electrochemical sensor of claim 51, wherein the auxiliary electrode is configured to be set at a potential of at least about +0.6 V.
0. 56. The electrochemical sensor of claim 51, wherein the auxiliary electrode is configured to electrochemically modify an electrochemical interferent to render the electrochemical interferent substantially electrochemically non-reactive at the working electrode.
0. 57. The electrochemical sensor of claim 56, wherein the auxiliary electrode is configured to be set at a potential of at least about +0.1 V.
0. 58. The electrochemical sensor of claim 51, configured for measuring a concentration of glucose in a fluid.
0. 59. The electrochemical sensor of claim 51, configured for measuring a concentration of glucose substantially without an oxygen deficit.
0. 61. The electrochemical sensor of claim 60, wherein the polymer comprises a material having a molecular weight that blocks glucose and allows transport therethrough of oxygen, urate, ascorbate, and acetaminophen.
0. 62. The electrochemical sensor of claim 60, wherein the auxiliary electrode comprises a conductive material selected from the group consisting of a conductive metal, a conductive polymer, and a blend of a conductive metal and a conductive polymer.
0. 63. The electrochemical sensor of claim 60, wherein the auxiliary electrode comprises a form selected from the group consisting of a mesh, a grid, and a plurality of spaced wires.
0. 64. The electrochemical sensor of claim 60, wherein the polymer comprises a material having a molecular weight that allows transport therethrough of urate, ascorbate, and acetaminophen.
0. 65. The electrochemical sensor of claim 60, wherein the auxiliary electrode is configured to be set at a potential of at least about +0.6 V.
0. 66. The electrochemical sensor of claim 60, wherein the auxiliary electrode is configured to electrochemically modify an electrochemical interferent to render the electrochemical interferent substantially electrochemically non-reactive at the working electrode.
0. 67. The electrochemical sensor of claim 66, wherein the auxiliary electrode is configured to be set at a potential of at least about +0.1 V.
0. 68. The electrochemical sensor of claim 60, configured for measuring a concentration of glucose in a fluid.
0. 69. The electrochemical sensor of claim 60, configured for insertion into a subcutaneous tissue of a host.
0. 70. The electrochemical sensor of claim 60, configured for implantation into a subcutaneous tissue of a host.
0. 71. The electrochemical sensor of claim 60, configured for measuring a concentration of glucose substantially without an oxygen deficit.
0. 73. The electrochemical sensor of claim 72, wherein the auxiliary electrode comprises a conductive material selected from the group consisting of a conductive metal, a conductive polymer, and a blend of a conductive metal and a conductive polymer.
0. 74. The electrochemical sensor of claim 72, wherein the auxiliary electrode comprises a form selected from the group consisting of a mesh, a grid, and a plurality of spaced wires.
0. 75. The electrochemical sensor of claim 72, wherein the polymer comprises a material that is permeable to an electrochemical interferent.
0. 76. The electrochemical sensor of claim 72, wherein the polymer comprises a material that is impermeable to glucose but is permeable to oxygen and interferents.
0. 77. The electrochemical sensor of claim 72, wherein the auxiliary electrode is configured to be set at a potential of at least about +0.1 V.
0. 78. The electrochemical sensor of claim 72, wherein the auxiliary electrode is configured to generate oxygen.
0. 79. The electrochemical sensor of claim 78, wherein the auxiliary electrode is configured to be set at a potential of at least about +0.6 V.
0. 80. The electrochemical sensor of claim 72, configured for measuring a concentration of glucose in a fluid.
0. 81. The electrochemical sensor of claim 72, configured for insertion into a subcutaneous tissue of a host.
0. 82. The electrochemical sensor of claim 72, configured for implantation into a subcutaneous tissue of a host.
0. 83. The electrochemical sensor of claim 72, configured for measuring a concentration of glucose substantially without an oxygen deficit.
0. 84. The electrochemical sensor of claim 72, wherein the auxiliary electrode is configured to generate oxygen.
0. 85. The electrochemical sensor of claim 84, wherein the auxiliary electrode is configured to be set at a potential of at least about +0.6 V.
0. 87. The electrochemical sensor of claim 86, wherein the auxiliary electrode comprises a conductive material selected from the group consisting of a conductive metal, a conductive polymer, and a blend of a conductive metal and a conductive polymer.
0. 88. The electrochemical sensor of claim 86, wherein the auxiliary electrode comprises a form selected from the group consisting of a mesh, a grid, and a plurality of spaced wires.
0. 89. The electrochemical sensor of claim 86, wherein the polymer comprises a material that is permeable to an electrochemical interferent.
0. 90. The electrochemical sensor of claim 86, wherein the polymer comprises a material that is permeable to interferents.
0. 91. The electrochemical sensor of claim 86, wherein the auxiliary electrode is configured to be set at a potential of at least about +0.1 V.
0. 92. The electrochemical sensor of claim 86, wherein the auxiliary electrode is configured to generate oxygen.
0. 93. The electrochemical sensor of claim 92, wherein the auxiliary electrode is configured to be set at a potential of at least about +0.6 V.
0. 94. The electrochemical sensor of claim 86, configured for measuring a concentration of glucose in a fluid.
0. 95. The electrochemical sensor of claim 86, configured for insertion into a subcutaneous tissue of a host.
0. 96. The electrochemical sensor of claim 86, configured for implantation into a subcutaneous tissue of a host.
0. 97. The electrochemical sensor of claim 86, configured for measuring a concentration of glucose substantially without an oxygen deficit.
0. 99. The sensor of claim 98, configured for measuring a concentration of glucose in a host.
0. 100. The sensor of claim 98, configured for insertion into contact with a subcutaneous tissue of a host.
0. 101. The sensor of claim 98, configured for communication with the intravascular system of a host.
0. 102. The sensor of claim 98, configured for continuous measurement of the analyte in a host.
0. 103. The sensor of claim 98, further comprising a potentiostat operably connected to the working electrode.
0. 104. The sensor of claim 103, wherein the potentiostat enables continuous measurement of the analyte in a host.
0. 105. The sensor of claim 98, further comprising sensor electronics operably connected to the working electrode, wherein the sensor electronics are configured to transmit data to a receiver.
0. 106. The sensor of claim 105, wherein the sensor electronics comprise an RF transceiver configured to wirelessly transmit the data to a receiver.
0. 107. The sensor of claim 98, wherein the membrane system is configured to limit diffusion of the analyte there through.
0. 108. The sensor of claim 107, wherein the membrane system further comprises a resistance domain configured to limit diffusion of the analyte there through.
0. 109. The sensor of claim 98, wherein the membrane system is configured to limit or block one or more interfering species there through.
0. 110. The sensor of claim 109, wherein the membrane system further comprises an interference domain configured to limit or block the one or more interfering species there through.
0. 111. The sensor of claim 109, wherein the membrane system further comprises an electrolyte domain configured to provide the hydrophilicity at the working electrode.
0. 112. The sensor of claim 98, wherein the membrane system is configured to provide a hydrophilicity at the working electrode.
0. 113. The sensor of claim 98, wherein the cell impermeable domain is located more distal from the working electrode than any other domain of the membrane system such that the cell impermeable domain directly contacts the host when placed into contact with the host's dermis, subcutaneous tissue and/or intravascular system.
0. 114. The sensor of claim 98, wherein the auxiliary electrode is located within the cell impermeable domain.
0. 115. The sensor of claim 98, wherein the auxiliary electrode is located between the cell impermeable domain and the enzyme domain.
0. 117. The sensor of claim 116, configured for measuring a concentration of glucose in a host.
0. 118. The sensor of claim 116, configured for insertion into contact with a subcutaneous tissue of a host.
0. 119. The sensor of claim 116, configured for communication with the intravascular system of a host.
0. 120. The sensor of claim 116, further comprising a potentiostat operably connected to the working electrode.
0. 121. The sensor of claim 120, wherein the potentiostat enables continuous measurement of the analyte in a host.
0. 122. The sensor of claim 116, further comprising sensor electronics operably connected to the working electrode, wherein the sensor electronics are configured to transmit data to a receiver.
0. 123. The sensor of claim 122, wherein the sensor electronics comprise an RF transceiver configured to wirelessly transmit the data to a receiver.
0. 124. The sensor of claim 116, wherein the membrane is configured to limit diffusion of the analyte there through.
0. 125. The sensor of claim 124, wherein the membrane further comprises a resistance domain configured to limit diffusion of the analyte there through.
0. 126. The sensor of claim 116, wherein the membrane is configured to limit or block one or more interfering species there through.
0. 127. The sensor of claim 126, wherein the membrane further comprises an interference domain configured to limit or block the one or more interfering species there through.
0. 128. The sensor of claim 116, wherein the membrane is configured to provide a hydrophilicity at the working electrode.
0. 129. The sensor of claim 128, wherein the membrane further comprises an electrolyte domain configured to provide the hydrophilicity at the working electrode.
0. 130. The sensor of claim 116, wherein the cell impermeable domain is located more distal from the working electrode than any other domain of the membrane such that the cell impermeable domain directly contacts the host when placed into contact with the host's dermis, subcutaneous tissue and/or intravascular system.
0. 131. The sensor of claim 116, wherein the auxiliary electrode is located within the outermost layer.
0. 132. The sensor of claim 116, wherein the auxiliary electrode is located between the outermost layer and the enzyme.
0. 134. The electrochemical sensor of claim 133, wherein the auxiliary electrode comprises a conductive material selected from the group consisting of a conductive metal, a conductive polymer, and a blend of a conductive metal and a conductive polymer.
0. 135. The electrochemical sensor of claim 133, wherein the auxiliary electrode comprises a form selected from the group consisting of a mesh, a grid, and a plurality of spaced wires.
0. 136. The electrochemical sensor of claim 133, wherein the polymer comprises a material that is permeable to interfering species.
0. 137. The electrochemical sensor of claim 136, wherein the polymer comprises a material having a molecular weight that allows transport therethrough of oxygen, urate, ascorbate, and acetaminophen.
0. 138. The electrochemical sensor of claim 133, wherein the auxiliary electrode is configured to be set at a potential of at least about +0.6 V.
0. 139. The electrochemical sensor of claim 133, wherein the auxiliary electrode is configured to electrochemically modify an electrochemical interferent to render the electrochemical interferent substantially electrochemically non-reactive at the working electrode.
0. 140. The electrochemical sensor of claim 139, wherein the auxiliary electrode is configured to be set at a potential of at least about +0.1 V.
0. 141. The electrochemical sensor of claim 133, configured for measuring a concentration of glucose in a fluid.
0. 142. The electrochemical sensor of claim 133, configured for measuring a concentration of glucose substantially without an oxygen deficit.
0. 144. The electrochemical sensor of claim 143, wherein the auxiliary electrode comprises a conductive material selected from the group consisting of a conductive metal, a conductive polymer, and a blend of a conductive metal and a conductive polymer.
0. 145. The electrochemical sensor of claim 143, wherein the auxiliary electrode comprises a form selected from the group consisting of a mesh, a grid, and a plurality of spaced wires.
0. 146. The electrochemical sensor of claim 143, wherein the polymer comprises a material that is permeable to interfering species.
0. 147. The electrochemical sensor of claim 146, wherein the polymer comprises a material having a molecular weight that allows transport therethrough of oxygen, urate, ascorbate, and acetaminophen.
0. 148. The electrochemical sensor of claim 143, wherein the auxiliary electrode is configured to be set at a potential of at least about +0.6 V.
0. 149. The electrochemical sensor of claim 143, wherein the auxiliary electrode is configured to electrochemically modify an electrochemical interferent to render the electrochemical interferent substantially electrochemically non-reactive at the working electrode.
0. 150. The electrochemical sensor of claim 149, wherein the auxiliary electrode is configured to be set at a potential of at least about +0.1 V.
0. 151. The electrochemical sensor of claim 143, configured for measuring a concentration of glucose in a fluid.
0. 152. The electrochemical sensor of claim 143, configured for measuring a concentration of glucose substantially without an oxygen deficit.
|
|||||||||||||||||||||||||||||
This application claims the benefit of priority under 35 U.S.C. § 119(e) to U.S. Provisional Application No. 60/490,007, filed Jul. 25, 2003, the contents of which are hereby incorporated by reference in their entirety.
The present invention relates generally to systems and methods for improving electrochemical sensor performance.
Electrochemical sensors are useful in chemistry and medicine to determine the presence or concentration of a biological analyte. Such sensors are useful, for example, to monitor glucose in diabetic patients and lactate during critical care events.
Diabetes mellitus is a disorder in which the pancreas cannot create sufficient insulin (Type I or insulin dependent) and/or in which insulin is not effective (Type 2 or non-insulin dependent). In the diabetic state, the victim suffers from high blood sugar, which causes an array of physiological derangements (kidney failure, skin ulcers, or bleeding into the vitreous of the eye) associated with the deterioration of small blood vessels. A hypoglycemic reaction (low blood sugar) is induced by an inadvertent overdose of insulin, or after a normal dose of insulin or glucose-lowering agent accompanied by extraordinary exercise or insufficient food intake.
Conventionally, a diabetic person carries a self-monitoring blood glucose (SMBG) monitor, which typically comprises uncomfortable finger pricking methods. Due to the lack of comfort and convenience, a diabetic will normally only measure his or her glucose level two to four times per day. Unfortunately, these time intervals are spread apart so far that the diabetic will likely find out too late, sometimes incurring dangerous side effects, of a hyperglycemic or hypoglycemic condition. It is not only unlikely that a diabetic will take a timely SMBG value, but additionally the diabetic will not know if their blood glucose value is going up (higher) or down (lower) based on conventional methods.
Consequently, a variety of transdermal and implantable electrochemical sensors are being developed for continuously detecting and/or quantifying blood glucose values. Many implantable glucose sensors suffer from complications within the body and provide only short-term or less-than-accurate working of blood glucose. Similarly, transdermal sensors have problems in accurately working and reporting back glucose values continuously over extended periods of time. Some efforts have been made to obtain blood glucose data from implantable devices and retrospectively determine blood glucose trends for analysis; however these efforts do not aid the diabetic in determining real-time blood glucose information. Some efforts have also been made to obtain blood glucose data from transdermal devices for prospective data analysis, however similar problems have occurred.
In contrast to the prior art, the sensors of preferred embodiments advantageously generate oxygen to allow the sensor to function at sufficient oxygen levels independent of the oxygen concentration in the surrounding environment. In another aspect of the preferred embodiments, systems and methods for modifying electrochemical interferants are provided.
Accordingly, in a first embodiment, an electrochemical sensor for determining a presence or a concentration of an analyte in a fluid is provided, the sensor comprising a membrane system comprising an enzyme, wherein the enzyme reacts with the analyte; an electroactive surface comprising a working electrode, the working electrode comprising a conductive material and configured to measure a product of the reaction of the enzyme with the analyte; and an auxiliary electrode comprising a conductive material and configured to generate oxygen, wherein the auxiliary electrode is situated such that the oxygen generated diffuses to the enzyme or to the electroactive surface.
In an aspect of the first embodiment, the auxiliary electrode comprises a conductive material selected from the group consisting of a conductive metal, a conductive polymer, and a blend of a conductive metal and a conductive polymer.
In an aspect of the first embodiment, the auxiliary electrode comprises a form selected from the group consisting of a mesh, a grid, and a plurality of spaced wires.
In an aspect of the first embodiment, the auxiliary electrode comprises a polymer, wherein the polymer is situated on a surface of the auxiliary electrode.
In an aspect of the first embodiment, the polymer comprises a material that is impermeable to glucose but is permeable to oxygen.
In an aspect of the first embodiment, the polymer comprises a material that is impermeable to glucose but is permeable to oxygen and permeable to interfering species.
In an aspect of the first embodiment, the polymer comprises a material having a molecular weight that blocks glucose and allows transport therethrough of oxygen, urate, ascorbate, and acetaminophen.
In an aspect of the first embodiment, the polymer comprises a material that is permeable to glucose and oxygen.
In an aspect of the first embodiment, the polymer comprises a material that is permeable to glucose, oxygen, and interfering species.
In an aspect of the first embodiment, the polymer comprises a material having a molecular weight that allows transport therethrough of oxygen, glucose, urate, ascorbate, and acetaminophen.
In an aspect of the first embodiment, the auxiliary electrode is configured to be set at a potential of at least about +0.6 V.
In an aspect of the first embodiment, the auxiliary electrode is configured to electrochemically modify an electrochemical interferant to render the electrochemical interferent substantially electrochemically non-reactive at the working electrode.
In an aspect of the first embodiment, the auxiliary electrode is configured to be set at a potential of at least about +0.1 V.
In a second embodiment, an electrochemical sensor for determining a presence or a concentration of an analyte in a fluid is provided, the sensor comprising a membrane system comprising an enzyme, wherein the enzyme reacts with the analyte; an electroactive surface comprising a working electrode, the working electrode comprising a conductive material and configured to measure a product of the reaction of the enzyme with the analyte; and an auxiliary electrode comprising a conductive material and configured to modify an electrochemical interferant such that the electrochemical interferent is rendered substantially electrochemically non-reactive at the working electrode.
In an aspect of the second embodiment, the auxiliary electrode comprises a conductive material selected from the group consisting of a conductive metal, a conductive polymer, and a blend of a conductive metal and a conductive polymer.
In an aspect of the second embodiment, the auxiliary electrode comprises a form selected from the group consisting of a mesh, a grid, and a plurality of spaced wires.
In an aspect of the second embodiment, the auxiliary electrode comprises a polymer, wherein the polymer is situated on a surface of the auxiliary electrode.
In an aspect of the second embodiment, the polymer comprises a material that is permeable to an electrochemical interferant.
In an aspect of the second embodiment, the polymer comprises a material that is impermeable to glucose but is permeable to oxygen.
In an aspect of the second embodiment, the polymer comprises a material that is impermeable to glucose but is permeable to oxygen and interferants.
In an aspect of the second embodiment, the polymer comprises a material having a molecular weight that blocks glucose and allows transport therethrough of oxygen, urate, ascorbate, and acetaminophen.
In an aspect of the second embodiment, the polymer comprises a material that is permeable to glucose and oxygen.
In an aspect of the second embodiment, the polymer comprises a material that is permeable to glucose, oxygen, and interferants.
In an aspect of the second embodiment, the polymer comprises a material having a molecular weight that allows transport therethrough of oxygen, glucose, urate, ascorbate, and acetaminophen.
In an aspect of the second embodiment, the auxiliary electrode is configured to be set at a potential of at least about +0.1V.
In an aspect of the second embodiment, the auxiliary electrode is configured to generate oxygen.
In an aspect of the second embodiment, the auxiliary electrode is configured to be set at a potential of at least about +0.6 V.
In a third embodiment, an electrochemical sensor is provided comprising an electroactive surface configured to measure an analyte; and an auxiliary interferant-modifying electrode configured to modify an electrochemical interferant such that the electrochemical interferant is rendered substantially non-reactive at the electroactive surface.
In an aspect of the third embodiment, the auxiliary interferant-modifying electrode comprises a conductive material selected from the group consisting of a conductive metal, a conductive polymer, and a blend of a conductive metal and a conductive polymer.
In an aspect of the third embodiment, the auxiliary interferant-modifying electrode comprises a form selected from the group consisting of a mesh, a grid, and a plurality of spaced wires.
In an aspect of the third embodiment, the auxiliary interferant-modifying electrode comprises a polymer, wherein the polymer is situated on a surface of the auxiliary interferant-modifying electrode.
The following description and examples illustrate some exemplary embodiments of the disclosed invention in detail. Those of skill in the art will recognize that there are numerous variations and modifications of this invention that are encompassed by its scope. Accordingly, the description of a certain exemplary embodiment should not be deemed to limit the scope of the present invention.
Definitions
In order to facilitate an understanding of the preferred embodiments, a number of terms are defined below.
The term “analyte” as used herein is a broad term and is used in its ordinary sense, including, without limitation, to refer to a substance or chemical constituent in a biological fluid (for example, blood, interstitial fluid, cerebral spinal fluid, lymph fluid or urine) that can be analyzed. Analytes can include naturally occurring substances, artificial substances, metabolites, and/or reaction products. In some embodiments, the analyte for measurement by the sensing regions, devices, and methods is glucose. However, other analytes are contemplated as well, including but not limited to acarboxyprothrombin; acylcarnitine; adenine phosphoribosyl transferase; adenosine deaminase; albumin; alpha-fetoprotein; amino acid profiles (arginine (Krebs cycle), histidine/urocanic acid, homocysteine, phenylalanine/tyrosine, tryptophan); andrenostenedione; antipyrine; arabinitol enantiomers; arginase; benzoylecgonine (cocaine); biotinidase; biopterin; c-reactive protein; carnitine; carnosinase; CD4; ceruloplasmin; chenodeoxycholic acid; chloroquine; cholesterol; cholinesterase; conjugated 1-β hydroxy-cholic acid; cortisol; creatine kinase; creatine kinase MM isoenzyme; cyclosporin A; d-penicillamine; de-ethylchloroquine; dehydroepiandrosterone sulfate; DNA (acetylator polymorphism, alcohol dehydrogenase, alpha 1-antitrypsin, cystic fibrosis, Duchenne/Becker muscular dystrophy, glucose-6-phosphate dehydrogenase, hemoglobin A, hemoglobin S, hemoglobin C, hemoglobin D, hemoglobin E, hemoglobin F, D-Punjab, beta-thalassemia, hepatitis B virus, HCMV, HIV-1, HTLV-1, Leber hereditary optic neuropathy, MCAD, RNA, PKU, Plasmodium vivax, sexual differentiation, 21-deoxycortisol); desbutylhalofantrine; dihydropteridine reductase; diptheria/tetanus antitoxin; erythrocyte arginase; erythrocyte protoporphyrin; esterase D; fatty acids/acylglycines; free β-human chorionic gonadotropin; free erythrocyte porphyrin; free thyroxine (FT4); free tri-iodothyronine (FT3); fumarylacetoacetase; galactose/gal-1-phosphate; galactose-1-phosphate uridyltransferase; gentamicin; glucose-6-phosphate dehydrogenase; glutathione; glutathione perioxidase; glycocholic acid; glycosylated hemoglobin; halofantrine; hemoglobin variants; hexosaminidase A; human erythrocyte carbonic anhydrase I; 17-alpha-hydroxyprogesterone; hypoxanthine phosphoribosyl transferase; immunoreactive trypsin; lactate; lead; lipoproteins ((a), B/A-1, β); lysozyme; mefloquine; netilmicin; phenobarbitone; phenytoin; phytanic/pristanic acid; progesterone; prolactin; prolidase; purine nucleoside phosphorylase; quinine; reverse tri-iodothyronine (rT3); selenium; serum pancreatic lipase; sissomicin; somatomedin C; specific antibodies (adenovirus, anti-nuclear antibody, anti-zeta antibody, arbovirus, Aujeszky's disease virus, dengue virus, Dracunculus medinensis, Echinococcus granulosus, Entamoeba histolytica, enterovirus, Giardia duodenalisa, Helicobacter pylori, hepatitis B virus, herpes virus, HIV-1, IgE (atopic disease), influenza virus, Leishmania donovani, leptospira, measles/mumps/rubella, Mycobacterium leprae, Mycoplasma pneumoniae, Myoglobin, Onchocerca volvulus, parainfluenza virus, Plasmodium falciparum, poliovirus, Pseudomonas aeruginosa, respiratory syncytial virus, rickettsia (scrub typhus), Schistosoma mansoni, Toxoplasma gondii, Trepenoma pallidium, Trypanosoma cruzi/rangeli, vesicular stomatis virus, Wuchereria bancrofti, yellow fever virus); specific antigens (hepatitis B virus, HIV-1); succinylacetone; sulfadoxine; theophylline; thyrotropin (TSH); thyroxine (T4); thyroxine-binding globulin; trace elements; transferrin; UDP-galactose-4-epimerase; urea; uroporphyrinogen I synthase; vitamin A; white blood cells; and zinc protoporphyrin. Salts, sugar, protein, fat, vitamins and hormones naturally occurring in blood or interstitial fluids can also constitute analytes in certain embodiments. The analyte can be naturally present in the biological fluid or endogenous, for example, a metabolic product, a hormone, an antigen, an antibody, and the like. Alternatively, the analyte can be introduced into the body or exogenous, for example, a contrast agent for imaging, a radioisotope, a chemical agent, a fluorocarbon-based synthetic blood, or a drug or pharmaceutical composition, including but not limited to insulin; ethanol; cannabis (marijuana, tetrahydrocannabinol, hashish); inhalants (nitrous oxide, amyl nitrite, butyl nitrite, chlorohydrocarbons, hydrocarbons); cocaine (crack cocaine); stimulants (amphetamines, methamphetamines, Ritalin, Cylert, Preludin, Didrex, PreState, Voranil, Sandrex, Plegine); depressants (barbituates, methaqualone, tranquilizers such as Valium, Librium, Miltown, Serax, Equanil, Tranxene); hallucinogens (phencyclidine, lysergic acid, mescaline, peyote, psilocybin); narcotics (heroin, codeine, morphine, opium, meperidine, Percocet, Percodan, Tussionex, Fentanyl, Darvon, Talwin, Lomotil); designer drugs (analogs of fentanyl, meperidine, amphetamines, methamphetamines, and phencyclidine, for example, Ecstasy); anabolic steroids; and nicotine. The metabolic products of drugs and pharmaceutical compositions are also contemplated analytes. Analytes such as neurochemicals and other chemicals generated within the body can also be analyzed, such as, for example, ascorbic acid, uric acid, dopamine, noradrenaline, 3-methoxytyramine (3MT), 3,4-dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA), 5-hydroxytryptamine (5HT), and 5-hydroxyindoleacetic acid (FHIAA).
The terms “operable connection,” “operably connected,” and “operably linked” as used herein are broad terms and are used in their ordinary sense, including, without limitation, one or more components linked to another component(s) in a manner that allows transmission of signals between the components. For example, one or more electrodes can be used to detect the amount of analyte in a sample and convert that information into a signal; the signal can then be transmitted to a circuit. In this case, the electrode is “operably linked” to the electronic circuitry.
The term “host” as used herein is a broad term and is used in its ordinary sense, including, without limitation, mammals, particularly humans.
The term “sensor,” as used herein, is a broad term and is used in its ordinary sense, including, without limitation, the portion or portions of an analyte-monitoring device that detects an analyte. In one embodiment, the sensor includes an electrochemical cell that has a working electrode, a reference electrode, and optionally a counter electrode passing through and secured within the sensor body forming an electrochemically reactive surface at one location on the body, an electronic connection at another location on the body, and a membrane system affixed to the body and covering the electrochemically reactive surface. During general operation of the sensor, a biological sample (for example, blood or interstitial fluid), or a portion thereof, contacts (directly or after passage through one or more membranes or domains) an enzyme (for example, glucose oxidase); the reaction of the biological sample (or portion thereof) results in the formation of reaction products that allow a determination of the analyte level in the biological sample.
The term “signal output,” as used herein, is a broad term and is used in its ordinary sense, including, without limitation, an analog or digital signal directly related to the measured analyte from the analyte-measuring device. The term broadly encompasses a single point, or alternatively, a plurality of time spaced data points from a substantially continuous glucose sensor, which comprises individual measurements taken at time intervals ranging from fractions of a second up to, for example, 1, 2, or 5 minutes or longer.
The term “electrochemical cell,” as used herein, is a broad term and is used in its ordinary sense, including, without limitation, a device in which chemical energy is converted to electrical energy. Such a cell typically consists of two or more electrodes held apart from each other and in contact with an electrolyte solution. Connection of the electrodes to a source of direct electric current renders one of them negatively charged and the other positively charged. Positive ions in the electrolyte migrate to the negative electrode (cathode) and there combine with one or more electrons, losing part or all of their charge and becoming new ions having lower charge or neutral atoms or molecules; at the same time, negative ions migrate to the positive electrode (anode) and transfer one or more electrons to it, also becoming new ions or neutral particles. The overall effect of the two processes is the transfer of electrons from the negative ions to the positive ions, a chemical reaction.
The term “potentiostat,” as used herein, is a broad term and is used in its ordinary sense, including, without limitation, an electrical system that controls the potential between the working and reference electrodes of a three-electrode cell at a preset value independent of resistance changes between the electrodes. It forces whatever current is necessary to flow between the working and counter electrodes to keep the desired potential, as long as the cell voltage and current do not exceed the compliance limits of the potentiostat.
The terms “electrochemically reactive surface” and “electroactive surface” as used herein are broad terms and are used in their ordinary sense, including, without limitation, the surface of an electrode where an electrochemical reaction takes place. In one example, a working electrode measures hydrogen peroxide produced by the enzyme catalyzed reaction of the analyte being detected reacts creating an electric current (for example, detection of glucose analyte utilizing glucose oxidase produces H2O2 as a by product, H2O2 reacts with the surface of the working electrode producing two protons (2H+), two electrons (2e−) and one molecule of oxygen (O2) which produces the electronic current being detected). In the case of the counter electrode, a reducible species, for example, O2 is reduced at the electrode surface in order to balance the current being generated by the working electrode.
The term “sensing region” as used herein is a broad term and is used in its ordinary sense, including, without limitation, the region of a monitoring device responsible for the detection of a particular analyte. The sensing region generally comprises a non-conductive body, a working electrode, a reference electrode, and optionally a counter electrode passing through and secured within the body forming electrochemically reactive surfaces on the body and an electronic connective means at another location on the body, and a multi-domain membrane system affixed to the body and covering the electrochemically reactive surface.
The terms “raw data stream” and “data stream,” as used herein, are broad terms and are used in their ordinary sense, including, without limitation, an analog or digital signal directly related to the measured an analyte from an analyte sensor. In one example, the raw data stream is digital data in “counts” converted by an A/D converter from an analog signal (for example, voltage or amps) representative of a analyte concentration. The terms broadly encompass a plurality of time spaced data points from a substantially continuous analyte sensor, which comprises individual measurements taken at time intervals ranging from fractions of a second up to, for example, 1, 2, or 5 minutes or longer.
The term “counts,” as used herein, is a broad term and is used in its ordinary sense, including, without limitation, a unit of measurement of a digital signal. In one example, a raw data stream measured in counts is directly related to a voltage (for example, converted by an A/D converter), which is directly related to current from the working electrode. In another example, counter electrode voltage measured in counts is directly related to a voltage.
The terms “electrical potential” and “potential” as used herein, are broad terms and are used in their ordinary sense, including, without limitation, the electrical potential difference between two points in a circuit which is the cause of the flow of a current.
The term “ischemia,” as used herein, is a broad term and is used in its ordinary sense, including, without limitation, local and temporary deficiency of blood supply due to obstruction of circulation to a part (for example, a sensor). Ischemia can be caused by mechanical obstruction (for example, arterial narrowing or disruption) of the blood supply, for example.
The term “system noise,” as used herein, is a broad term and is used in its ordinary sense, including, without limitation, unwanted electronic or diffusion-related noise which can include Gaussian, motion-related, flicker, kinetic, or other white noise, for example.
The terms “signal artifacts” and “transient non-glucose related signal artifacts that have a higher amplitude than system noise,” as used herein, are broad terms and are used in their ordinary sense, including, without limitation, signal noise that is caused by substantially non-glucose reaction rate-limiting phenomena, such as ischemia, pH changes, temperature changes, pressure, and stress, for example. Signal artifacts, as described herein, are typically transient and characterized by a higher amplitude than system noise.
The term “low noise,” as used herein, is a broad term and is used in its ordinary sense, including, without limitation, noise that substantially decreases signal amplitude.
The terms “high noise” and “high spikes,” as used herein, are broad terms and are used in their ordinary sense, including, without limitation, noise that substantially increases signal amplitude.
The phrase “distal to” as used herein is a broad term and is used in its ordinary sense, including, without limitation, the spatial relationship between various elements in comparison to a particular point of reference. For example, some embodiments of a device include a membrane system having a cell disruptive domain and a cell impermeable domain. If the sensor is deemed to be the point of reference and the cell disruptive domain is positioned farther from the sensor, then that domain is distal to the sensor.
The phrase “proximal to” as used herein is a broad term and is used in its ordinary sense, including, without limitation, the spatial relationship between various elements in comparison to a particular point of reference. For example, some embodiments of a device include a membrane system having a cell disruptive domain and a cell impermeable domain. If the sensor is deemed to be the point of reference and the cell impermeable domain is positioned nearer to the sensor, then that domain is proximal to the sensor.
The terms “interferants” and “interfering species,” as used herein, are broad terms and are used in their ordinary sense, including, but not limited to, effects and/or species that interfere with the measurement of an analyte of interest in a sensor to produce a signal that does not accurately represent the analyte measurement. In one example of an electrochemical sensor, interfering species are compounds with an oxidation potential that overlaps with the analyte to be measured.
As employed herein, the following abbreviations apply: Eq and Eqs (equivalents); mEq (milliequivalents); M (molar); mM (millimolar) μM (micromolar); N (Normal); mol (moles); mmol (millimoles); μmol (micromoles); nmol (nanomoles); g (grams); mg (milligrams); μg (micrograms); Kg (kilograms); L (liters); mL (milliliters); dL (deciliters); μL (microliters); cm (centimeters); mm (millimeters); μm (micrometers); nm (nanometers); h and hr (hours); min. (minutes); s and sec. (seconds); ° C. (degrees Centigrade).
Overview
The preferred embodiments relate to the use of an electrochemical sensor that measures a concentration of an analyte of interest or a substance indicative of the concentration or presence of the analyte in fluid. In some embodiments, the sensor is a continuous device, for example a subcutaneous, transdermal, or intravascular device. In some embodiments, the device can analyze a plurality of intermittent blood samples.
The sensor uses any known method, including invasive, minimally invasive, and non-invasive sensing techniques, to provide an output signal indicative of the concentration of the analyte of interest. The sensor is of the type that senses a product or reactant of an enzymatic reaction between an analyte and an enzyme in the presence of oxygen as a measure of the analyte in vivo or in vitro. Such a sensor typically comprises a membrane surrounding the enzyme through which a bodily fluid passes and in which an analyte within the bodily fluid reacts with an enzyme in the presence of oxygen to generate a product. The product is then measured using electrochemical methods and thus the output of an electrode system functions as a measure of the analyte. In some embodiments, the sensor can use an amperometric, coulometric, conductimetric, and/or potentiometric technique for measuring the analyte. In some embodiments, the electrode system can be used with any of a variety of known in vitro or in vivo analyte sensors or monitors.
In this embodiment, the electrode system 16 is operably connected to the sensor electronics (
In the embodiment of
GOX+Glucose+O2→Gluconate+H2O2+reduced GOX
The change in H2O2 can be monitored to determine glucose concentration because for each glucose molecule metabolized, there is a proportional change in the product H2O2. Oxidation of H2O2 by the working electrode is balanced by reduction of ambient oxygen, enzyme generated H2O2, or other reducible species at the counter electrode. The H2O2 produced from the glucose oxidase reaction further reacts at the surface of working electrode and produces two protons (2H+), two electrons (2e−), and one oxygen molecule (O2). In such embodiments, because the counter electrode utilizes oxygen as an electron acceptor, the most likely reducible species for this system are oxygen or enzyme generated peroxide. There are two main pathways by which oxygen can be consumed at the counter electrode. These pathways include a four-electron pathway to produce hydroxide and a two-electron pathway to produce hydrogen peroxide. In addition to the counter electrode, oxygen is further consumed by the reduced glucose oxidase within the enzyme domain. Therefore, due to the oxygen consumption by both the enzyme and the counter electrode, there is a net consumption of oxygen within the electrode system. Theoretically, in the domain of the working electrode there is significantly less net loss of oxygen than in the region of the counter electrode. In some embodiments, there is a close correlation between the ability of the counter electrode to maintain current balance and sensor function.
In general, in electrochemical sensors wherein an enzymatic reaction depends on oxygen as a co-reactant, depressed function or inaccuracy can be experienced in low oxygen environments, for example in vivo. Subcutaneously implanted devices are especially susceptible to transient ischemia that can compromise device function; for example, because of the enzymatic reaction required for an implantable amperometric glucose sensor, oxygen must be in excess over glucose in order for the sensor to effectively function as a glucose sensor. If glucose becomes in excess, the sensor turns into an oxygen sensitive device. In vivo, glucose concentration can vary from about one hundred times or more that of the oxygen concentration. Consequently, one limitation of prior art enzymatic-based electrochemical analyte sensors can be caused by oxygen deficiencies, which is described in more detail with reference to
A microprocessor 22 is the central control unit that houses EEPROM 23 and SRAM 24, and controls the processing of the sensor electronics. The alternative embodiments can utilize a computer system other than a microprocessor to process data as described herein. In some alternative embodiments, an application-specific integrated circuit (ASIC) can be used for some or all the sensor's central processing. EEPROM 23 provides semi-permanent storage of data, storing data such as sensor ID and necessary programming to process data signals (for example, programming for data smoothing such as described elsewhere herein). SRAM 24 is used for the system's cache memory, for example for temporarily storing recent sensor data.
The battery 25 is operatively connected to the microprocessor 22 and provides the necessary power for the sensor. In one embodiment, the battery is a Lithium Manganese Dioxide battery, however any appropriately sized and powered battery can be used. In some embodiments, a plurality of batteries can be used to power the system. Quartz crystal 26 is operatively connected to the microprocessor 22 and maintains system time for the computer system.
The RF Transceiver 27 is operably connected to the microprocessor 22 and transmits the sensor data from the sensor to a receiver. Although a RF transceiver is shown here, some other embodiments can include a wired rather than wireless connection to the receiver. In yet other embodiments, the sensor can be transcutaneously connected via an inductive coupling, for example. The quartz crystal 28 provides the system time for synchronizing the data transmissions from the RF transceiver. The transceiver 27 can be substituted with a transmitter in one embodiment.
Although
In one situation, when oxygen is deficient relative to the amount of glucose, then the enzymatic reaction is limited by oxygen rather than glucose. Thus, the output signal is indicative of the oxygen concentration rather than the glucose concentration, producing erroneous signals. Additionally, when an enzymatic reaction is rate-limited by oxygen, glucose is expected to build up in the membrane because it is not completely catabolized during the oxygen deficit. When oxygen is again in excess, there is also excess glucose due to the transient oxygen deficit. The enzyme rate then speeds up for a short period until the excess glucose is catabolized, resulting in spikes of non-glucose related increased sensor output. Accordingly, because excess oxygen (relative to glucose) is necessary for proper sensor function, transient ischemia can result in a loss of signal gain in the sensor data.
In another situation, oxygen deficiency can be seen at the counter electrode when insufficient oxygen is available for reduction, which thereby affects the counter electrode in that it is unable to balance the current coming from the working electrode. When insufficient oxygen is available for the counter electrode, the counter electrode can be driven in its electrochemical search for electrons all the way to its most negative value, which could be ground or 0.0 V, which causes the reference to shift, reducing the bias voltage, such is as described in more detail below. In other words, a common result of ischemia a drop off in sensor current as a function of glucose concentration (for example, lower sensitivity). This happens because the working electrode no longer oxidizes all of the H2O2 arriving at its surface because of the reduced bias. In some extreme circumstances, an increase in glucose can produce no increase in current or even a decrease in current.
In some situations, transient ischemia can occur at high glucose levels, wherein oxygen can become limiting to the enzymatic reaction, resulting in a non-glucose dependent downward trend in the data. In some situations, certain movements or postures taken by the patient can cause transient signal artifacts as blood is squeezed out of the capillaries resulting in local ischemia and causing non-glucose dependent signal artifacts. In some situations, oxygen can also become transiently limited due to contracture of tissues around the sensor interface. This is similar to the blanching of skin that can be observed when one puts pressure on it. Under such pressure, transient ischemia can occur in both the epidermis and subcutaneous tissue. Transient ischemia is common and well tolerated by subcutaneous tissue. However, such ischemic periods can cause an oxygen deficit in implanted devices that can last for many minutes or even an hour or longer.
Although some examples of the effects of transient ischemia on a prior art glucose sensor are described above, similar effects can be seen with analyte sensors that use alternative catalysts to detect other analytes, for example, amino acids (amino acid oxidase), alcohol (alcohol oxidase), galactose (galactose oxidase), lactate (lactate oxidase), cholesterol (cholesterol oxidase), or the like.
Another problem with conventional electrochemical sensors is that they can electrochemically react not only with the analyte to be measured (or by-product of the enzymatic reaction with the analyte), but additionally can react with other electroactive species that are not intentionally being measured (for example, interfering species), which causes an increase in signal strength due to these “interfering species”. In other words, interfering species are compounds with an oxidation or reduction potential that overlaps with the analyte to be measured (or the by-product of the enzymatic reaction with the analyte). For example, in a conventional amperometric glucose oxidase-based glucose sensor wherein the sensor measures hydrogen peroxide, interfering species such as acetaminophen, ascorbate, and urate are known to produce inaccurate signal strength when they are not properly controlled.
Some conventional glucose sensors utilize a membrane system that blocks at least some interfering species, such as ascorbate and urate. In some such systems, at least one layer of the membrane system includes a porous structure that has a relatively impermeable matrix with a plurality of “micro holes” or pores of molecular dimensions, such that transfer through these materials is primarily due to passage of species through the pores (for example, the layer acts as a microporous barrier or sieve blocking interfering species of a particular size). In other such systems, at least one layer of the membrane system defines a permeability that allows selective dissolution and diffusion of species as solutes through the layer. Unfortunately, it is difficult to find membranes that are satisfactory or reliable in use, especially in vivo, which effectively block all interferants and/or interfering species in some embodiments.
Electrochemical Sensors of the Preferred Embodiments
In one aspect of the preferred embodiments, an electrochemical sensor is provided with an auxiliary electrode configured to generate oxygen in order to overcome the effects of transient ischemia. In another aspect of the preferred embodiments, an electrochemical sensor is provided with an auxiliary electrode configured to electrochemically modify (for example, oxidize or reduce) electrochemical interferants to render them substantially non-electroactively reactive at the electroactive sensing surface(s) in order to overcome the effects of interferants on the working electrode.
It is known that oxygen can be generated as a product of electrochemical reactions occurring at a positively charged electrode (for example, set at about +0.6 to about +1.2 V or more). One example of an oxygen producing reaction is the electrolysis of water, which creates oxygen at the anode (for example, the working electrode). In the exemplary electrochemical glucose sensor, glucose is converted to hydrogen peroxide by reacting with glucose oxidase and oxygen, after which the hydrogen peroxide is oxidized at the working electrode and oxygen is generated therefrom. It is noted that one challenge to generating oxygen electrochemically in this way is that while an auxiliary electrode does produce excess oxygen, the placement of the auxiliary electrode in proximity to the analyte-measuring working electrode can cause oxidation of hydrogen peroxide at the auxiliary electrode, resulting in reduced signals at the working electrode. It is also known that many electrochemical interferants can be reduced at a potential of from about +0.1V to +1.2V or more; for example, acetaminophen is reduced at a potential of about +0.4 V.
Accordingly, the sensors of preferred embodiments place an auxiliary electrode above the electrode system 16, or other electroactive sensing surface, thereby reducing or eliminating the problem of inaccurate signals as described above.
The membrane system 18 includes a plurality of domains (for example, cell impermeable domain, resistance domain, enzyme domain, and/or other domains such as are described in U.S. Published Patent Application 2003/0032874 to Rhodes et al. and copending U.S. patent application Ser. No. 10/885,476, filed Jul. 6, 2004 and entitled, “SYSTEMS AND METHODS FOR MANUFACTURE OF AN ANALYTE-MEASURING DEVICE INCLUDING A MEMBRANE SYSTEM”, the contents of which are incorporated herein by reference in their entireties) is located proximal to the external solution and finctions to transport fluids necessary for the enzymatic reaction, while protecting inner components of the sensor from harsh biohazards, for example. Although each domain is not independently shown, the enzyme 38 is shown disposed between an auxiliary electrode 36 and the working electrode 16a in the illustrated embodiment.
Preferably, the auxiliary electrode 36 is located within or adjacent to the membrane system 18, for example, between the enzyme and other domains, although the auxiliary electrode can be placed anywhere between the electroactive sensing surface and the outside fluid. The auxiliary electrode 36 is formed from known working electrode materials (for example, platinum, palladium, graphite, gold, carbon, conductive polymer, or the like) and has a voltage setting that produces oxygen (for example, from about +0.6 V to +1.2 V or more) and/or that electrochemically modifies (for example, reduces) electrochemical interferants to render them substantially non-reactive at the electroactive sensing surface(s) (for example, from about +0.1 V to +1.2 V or more). The auxiliary electrode can be a mesh, grid, plurality of spaced wires or conductive polymers, or other configurations designed to allow analytes to penetrate therethrough.
In the aspect of the preferred embodiments wherein the auxiliary electrode 36 is configured to generate oxygen, the oxygen generated from the auxiliary electrode 36 diffuses upward and/or downward to be utilized by the enzyme 38 and/or the counter electrode (depending on the placement of the auxiliary electrode). Additionally, the analyte (for example, glucose) from the outside solution (diffuses through the auxiliary electrode 36) reacts with the enzyme 38 and produces a measurable product (for example, hydrogen peroxide). Therefore, the product of the enzymatic reaction diffuses down to the working electrode 16a for accurate measurement without being eliminated by the auxiliary electrode 36.
In one alternative embodiment, the auxiliary electrode 36 can be coated with a polymeric material, which is impermeable to glucose but permeable to oxygen. By this coating, glucose will not electroactively react at the auxiliary electrode 36, which can otherwise cause at least some of the glucose to pre-oxidize as it passes through the auxiliary electrode 36 (when placed above the enzyme), which can prevent accurate glucose concentration measurements at the working electrode in some sensor configurations. In one embodiment, the polymer coating comprises silicone, however any polymer that is selectively permeable to oxygen, but not glucose, can be used. The auxiliary electrode 16 can be coated by any known process, such as dip coating or spray coating, after which is can be blown, blotted, or the like to maintain spaces within the electrode for glucose transport.
In another alternative embodiment, the auxiliary electrode 36 can be coated with a polymeric material that is permeable to glucose and oxygen and can be placed between the enzyme and the outside fluid. Consequently, the polymeric coating will cause glucose from the outside fluid to electroactively react at the auxiliary electrode 36, thereby limiting the amount of glucose that passes into the enzyme 38, and thus reducing the amount of oxygen necessary to successfully react with all available glucose in the enzyme. The polymeric material can function in place of or in combination with the resistance domain in order to limit the amount of glucose that passes through the membrane system. This embodiment assumes a stoichiometric relationship between glucose oxidation and decreased sensor signal output, which can be compensated for by calibration in some sensor configurations. Additionally, the auxiliary electrode generates oxygen, further reducing the likelihood of oxygen becoming a rate-limiting factor in the enzymatic reaction and/or at the counter electrode, for example.
In another aspect of the preferred embodiments, the auxiliary electrode 36 is configured to electrochemically modify (for example, oxidize or reduce) electrochemical interferants to render them substantially non-reactive at the electroactive sensing surface(s). In these embodiments, which can be in addition to or alternative to the above-described oxygen-generating embodiments, a polymer coating is chosen to selectively allow interferants (for example, urate, ascorbate, and/or acetaminophen such as described in U.S. Pat. No. 6,579,690 to Bonnecaze, et al.) to pass through the coating and electrochemically react with the auxiliary electrode, which effectively pre-oxidizes the interferants, rendering them substantially non-reactive at the working electrode 16a. In one exemplary embodiment, silicone materials can be synthesized to allow the transport of oxygen, acetaminophen and other interferants, but not allow the transport of glucose. In some embodiments, the polymer coating material can be chosen with a molecular weight that blocks glucose and allows the transport of oxygen, urate, ascorbate, and acetaminophen. In another exemplary embodiment, silicone materials can be synthesized to allow the transport of oxygen, glucose, acetaminophen, and other interferants. In some embodiments, the polymer coating material is chosen with a molecular weight that allows the transport of oxygen, glucose, urate, ascorbate, and acetaminophen. The voltage setting necessary to react with interfering species depends on the target electrochemical interferants, for example, from about +0.1 V to about +1.2 V. In some embodiments, wherein the auxiliary electrode is set at a potential of from about +0.6 to about +1.2 V, both oxygen-generation and electrochemical interferant modification can be achieved. In some embodiments, wherein the auxiliary electrode is set at a potential below about +0.6 V, the auxiliary electrode will function mainly to electrochemically modify interferants, for example.
Therefore, the sensors of preferred embodiments reduce or eliminate oxygen deficiency problems within electrochemical sensors by producing oxygen at an auxiliary electrode located above the enzyme within an enzyme-based electrochemical sensor. Additionally or alternatively, the sensors of preferred embodiments reduce or eliminate interfering species problems by electrochemically reacting with interferants at the auxiliary electrode rendering them substantially non-reactive at the working electrode.
Methods and devices that are suitable for use in conjunction with aspects of the preferred embodiments are disclosed in co-pending U.S. patent application Ser. No. 10/842,716, filed May 10, 2004 and entitled, “MEMBRANE SYSTEMS INCORPORATING BIOACTIVE AGENTS”; co-pending U.S. patent application Ser. No. 10/838,912 filed May 3, 2004 and entitled, “IMPLANTABLE ANALYTE SENSOR”; U.S. patent application Ser. No. 10/789,359 filed Feb. 26, 2004 and entitled, “INTEGRATED DELIVERY DEVICE FOR A CONTINUOUS GLUCOSE SENSOR”; U.S. application Ser. No. 10/685,636 filed Oct. 28, 2003 and entitled, “SILICONE COMPOSITION FOR MEMBRANE SYSTEM”; U.S. application Ser. No. 10/648,849 filed Aug. 22, 2003 and entitled, “SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM”; U.S. application Ser. No. 10/646,333 filed Aug. 22, 2003 entitled, “OPTIMIZED SENSOR GEOMETRY FOR AN IMPLANTABLE GLUCOSE SENSOR”; U.S. application Ser. No. 10/647,065 filed Aug. 22, 2003 entitled, “POROUS MEMBRANES FOR USE WITH IMPLANTABLE DEVICES”; U.S. application Ser. No. 10/633,367 filed Aug. 1, 2003 entitled, “SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA”; U.S. Pat. No. 6,702,857 entitled “MEMBRANE FOR USE WITH IMPLANTABLE DEVICES”; U.S. application Ser. No. 09/916,711 filed Jul. 27, 2001 and entitled “SENSOR HEAD FOR USE WITH IMPLANTABLE DEVICE”; U.S. application Ser. No. 09/447,227 filed Nov. 22, 1999 and entitled “DEVICE AND METHOD FOR DETERMINING ANALYTE LEVELS”; U.S. application Ser. No. 10/153,356 filed May 22, 2002 and entitled “TECHNIQUES TO IMPROVE POLYURETHANE MEMBRANES FOR IMPLANTABLE GLUCOSE SENSORS”; U.S. application Ser. No. 09/489,588 filed Jan. 21, 2000 and entitled “DEVICE AND METHOD FOR DETERMINING ANALYTE LEVELS”; U.S. application Ser. No. 09/636,369 filed Aug. 11, 2000 and entitled “SYSTEMS AND METHODS FOR REMOTE MONITORING AND MODULATION OF MEDICAL DEVICES”; and U.S. application Ser. No. 09/916,858 filed Jul. 27, 2001 and entitled “DEVICE AND METHOD FOR DETERMINING ANALYTE LEVELS,” as well as issued patents including U.S. Pat. No. 6,001,067 issued Dec. 14, 1999 and entitled “DEVICE AND METHOD FOR DETERMINING ANALYTE LEVELS”; U.S. Pat. No. 4,994,167 issued Feb. 19, 1991 and entitled “BIOLOGICAL FLUID MEASURING DEVICE”; and U.S. Pat. No. 4,757,022 filed Jul. 12, 1988 and entitled “BIOLOGICAL FLUID MEASURING DEVICE”; U.S. application Ser. No. 60/489,615 filed Jul. 23, 2003 and entitled “ROLLED ELECTRODE ARRAY AND ITS METHOD FOR MANUFACTURE”; U.S. application Ser. No. 60/490,010 filed Jul. 25, 2003 and entitled “INCREASING BIAS FOR OXYGEN PRODUCTION IN AN ELECTRODE ASSEMBLY”; U.S. application Ser. No. 60/490,009 filed Jul. 25, 2003 and entitled “OXYGEN ENHANCING ENZYME MEMBRANE FOR ELECTROCHEMICAL SENSORS”; U.S. application Ser. No. 60/490,007 filed Jul. 25, 2003 and entitled “OXYGEN-GENERATING ELECTRODE FOR USE IN ELECTROCHEMICAL SENSORS”; U.S. application Ser. No. 10/896,637 filed Jul. 21, 2004 and entitled “ROLLED ELECTRODE ARRAY AND ITS METHOD FOR MANUFACTURE”; U.S. application Ser. No. 10/896,772 filed Jul. 21, 2004 and entitled “INCREASING BIAS FOR OXYGEN PRODUCTION IN AN ELECTRODE SYSTEM”; U.S. application Ser. No. 10/896,639 filed Jul. 21, 2004 and entitled “OXYGEN ENHANCING MEMBRANE SYSTEMS FOR IMPLANTABLE DEVICES”; U.S. application Ser. No. 10/897,377 filed Jul. 21, 2004 and entitled “ELECTROCHEMICAL SENSORS INCLUDING ELECTRODE SYSTEMS WITH INCREASED OXYGEN GENERATION”. The foregoing patent applications and patents are incorporated herein by reference in their entireties.
All references cited herein are incorporated herein by reference in their entireties. To the extent publications and patents or patent applications incorporated by reference contradict the disclosure contained in the specification, the specification is intended to supersede and/or take precedence over any such contradictory material.
The term “comprising” as used herein is synonymous with “including,” “containing,” or “characterized by,” and is inclusive or open-ended and does not exclude additional, unrecited elements or method steps.
All numbers expressing quantities of ingredients, reaction conditions, and so forth used in the specification and claims are to be understood as being modified in all instances by the term “about.” Accordingly, unless indicated to the contrary, the numerical parameters set forth in the specification and attached claims are approximations that can vary depending upon the desired properties sought to be obtained by the present invention. At the very least, and not as an attempt to limit the application of the doctrine of equivalents to the scope of the claims, each numerical parameter should be construed in light of the number of significant digits and ordinary rounding approaches.
The above description discloses several methods and materials of the present invention. This invention is susceptible to modifications in the methods and materials, as well as alterations in the fabrication methods and equipment. Such modifications will become apparent to those skilled in the art from a consideration of this disclosure or practice of the invention disclosed herein. Consequently, it is not intended that this invention be limited to the specific embodiments disclosed herein, but that it cover all modifications and alternatives coming within the true scope and spirit of the invention as embodied in the attached claims.
Brauker, James H., Petisce, James R., Simpson, Peter C., Carr-Brendel, Victoria E.
| Patent | Priority | Assignee | Title |
| 10118035, | Feb 24 2015 | ELIRA, INC | Systems and methods for enabling appetite modulation and/or improving dietary compliance using an electro-dermal patch |
| 10143840, | Feb 24 2015 | ELIRA, INC | Systems and methods for enabling appetite modulation and/or improving dietary compliance using an electro-dermal patch |
| 10335302, | Feb 24 2015 | ELIRA, INC | Systems and methods for using transcutaneous electrical stimulation to enable dietary interventions |
| 10376145, | Feb 24 2015 | ELIRA, INC | Systems and methods for enabling a patient to achieve a weight loss objective using an electrical dermal patch |
| 10765863, | Feb 24 2015 | ELIRA, INC | Systems and methods for using a transcutaneous electrical stimulation device to deliver titrated therapy |
| 10864367, | Feb 24 2015 | ELIRA, INC | Methods for using an electrical dermal patch in a manner that reduces adverse patient reactions |
| 10980461, | Nov 07 2008 | DexCom, Inc. | Advanced analyte sensor calibration and error detection |
| 11000215, | Nov 07 2008 | DEXCOM, INC | Analyte sensor |
| 11020031, | Nov 07 2008 | DEXCOM, INC | Analyte sensor |
| 11197613, | Feb 24 2015 | Elira, Inc. | Systems and methods for enabling a patient to achieve a weight loss objective using an electrical dermal patch |
| 11382539, | Oct 04 2006 | DexCom, Inc. | Analyte sensor |
| 11478194, | Jul 29 2020 | Biolinq Incorporated | Continuous analyte monitoring system with microneedle array |
| 11712562, | Feb 24 2015 | Systems and methods for using a transcutaneous electrical stimulation device to deliver titrated therapy | |
| 11857344, | May 08 2021 | Biolinq Incorporated | Fault detection for microneedle array based continuous analyte monitoring device |
| 11872055, | Jul 29 2020 | Biolinq Incorporated | Continuous analyte monitoring system with microneedle array |
| 11950902, | Aug 02 2019 | Bionime Corporation | Micro biosensor and method for reducing measurement interference using the same |
| 11957895, | Feb 24 2015 | Glucose-based modulation of electrical stimulation to enable weight loss | |
| 11963796, | Apr 29 2017 | Biolinq Incorporated | Heterogeneous integration of silicon-fabricated solid microneedle sensors and CMOS circuitry |
| 9956393, | Feb 24 2015 | ELIRA, INC | Systems for increasing a delay in the gastric emptying time for a patient using a transcutaneous electro-dermal patch |
| ER5521, | |||
| ER9026, |
| Patent | Priority | Assignee | Title |
| 1564641, | |||
| 2402306, | |||
| 3210578, | |||
| 3381371, | |||
| 3775182, | |||
| 3826244, | |||
| 3838033, | |||
| 3933593, | Feb 27 1967 | Beckman Instruments, Inc. | Rate sensing batch analysis method |
| 3982530, | Apr 22 1975 | Penial appliance | |
| 4052754, | Aug 14 1975 | TRANQUIL PROSPECTS, LTD , A COMPANY OF THE BRITISH VIRGIN ISLANDS | Implantable structure |
| 4067322, | Jul 19 1974 | ANDOVER MEDICAL INCORPORATED, 341 MIDDLESEX STREET, MA | Disposable, pre-gel body electrodes |
| 4197840, | Nov 06 1975 | BBC Brown Boveri & Company, Limited | Permanent magnet device for implantation |
| 4240889, | Jan 28 1978 | Toyo Boseki Kabushiki Kaisha | Enzyme electrode provided with immobilized enzyme membrane |
| 4255500, | Mar 29 1979 | GATES ENERGY PRODUCTS, INC | Vibration resistant electrochemical cell having deformed casing and method of making same |
| 4324257, | Feb 20 1978 | HONEYWELL B V AMSTERDAM,A SUBSIDIARY OF THE NETHERLANDS OF HONEYWELL INC A DE CORP | Device for the transcutaneous measurement of the partial oxygen pressure in blood |
| 4374013, | Mar 06 1980 | Oxygen stabilized enzyme electrode | |
| 4378016, | Jul 15 1981 | BIOTEK, Inc. | Artificial endocrine gland containing hormone-producing cells |
| 4388166, | Aug 14 1979 | Tokyo Shibaura Denki Kabushiki Kaisha | Electrochemical measuring apparatus provided with an enzyme electrode |
| 4402694, | Jul 16 1981 | BIOTEK, Inc. | Body cavity access device containing a hormone source |
| 4418148, | Nov 05 1981 | Miles Laboratories, Inc. | Multilayer enzyme electrode membrane |
| 4431004, | Oct 27 1981 | Implantable glucose sensor | |
| 4431507, | Jan 14 1981 | Matsushita Electric Industrial Co., Ltd. | Enzyme electrode |
| 4442841, | Apr 30 1981 | Mitsubishi Rayon Company Limited | Electrode for living bodies |
| 4477314, | Jul 30 1982 | Siemens Aktiengesellschaft | Method for determining sugar concentration |
| 4484987, | May 19 1983 | The Regents of the University of California | Method and membrane applicable to implantable sensor |
| 4494950, | Jan 19 1982 | The Johns Hopkins University | Plural module medication delivery system |
| 4545382, | Oct 23 1981 | MEDISENSE, INC | Sensor for components of a liquid mixture |
| 4571292, | Aug 12 1982 | Case Western Reserve University | Apparatus for electrochemical measurements |
| 4578215, | Aug 12 1983 | Micro-Circuits Company | Electrical conductivity-enhancing and protecting material |
| 4650547, | May 19 1983 | The Regents of the University of California | Method and membrane applicable to implantable sensor |
| 4655880, | Aug 01 1983 | Case Western Reserve University | Apparatus and method for sensing species, substances and substrates using oxidase |
| 4671288, | Jun 13 1985 | The Regents of the University of California | Electrochemical cell sensor for continuous short-term use in tissues and blood |
| 4672970, | Jul 30 1984 | Mitsubishi Rayon Company, Ltd. | Electrode for living body |
| 4680268, | Sep 18 1985 | CHILDREN S HOSPITAL MEDICAL CENTER, ELLAND AND BETHESDA AVENUES, CINCINNATI OHIO 45229, A CORP OF OHIO; CHILDREN S HOSPITAL MEDICAL CENTER, A NON-PROFIT ORGANIZATION OF OHIO | Implantable gas-containing biosensor and method for measuring an analyte such as glucose |
| 4685463, | Apr 03 1986 | Device for continuous in vivo measurement of blood glucose concentrations | |
| 4703756, | May 06 1986 | Regents of the University of California, The | Complete glucose monitoring system with an implantable, telemetered sensor module |
| 4711245, | Oct 22 1982 | MEDISENSE, INC | Sensor for components of a liquid mixture |
| 4721677, | Sep 18 1985 | Children's Hospital Medical Center | Implantable gas-containing biosensor and method for measuring an analyte such as glucose |
| 4726381, | Jun 04 1986 | Solutech, Inc. | Dialysis system and method |
| 4750496, | Jan 28 1987 | PHARMACONTROL CORP A CORP OF NEW JERSEY | Method and apparatus for measuring blood glucose concentration |
| 4757022, | Sep 10 1985 | DEXCOM, INC | Biological fluid measuring device |
| 4763658, | Jun 04 1986 | Solutech, Inc. | Dialysis system 2nd method |
| 4776944, | Mar 20 1986 | Chemical selective sensors utilizing admittance modulated membranes | |
| 4781798, | Apr 19 1985 | The Regents of the University of California | Transparent multi-oxygen sensor array and method of using same |
| 4786657, | Jul 02 1987 | Minnesota Mining and Manufacturing Company | Polyurethanes and polyurethane/polyureas crosslinked using 2-glyceryl acrylate or 2-glyceryl methacrylate |
| 4795542, | Apr 24 1986 | St. Jude Medical, Inc. | Electrochemical concentration detector device |
| 4813424, | Dec 23 1987 | University of New Mexico | Long-life membrane electrode for non-ionic species |
| 4822336, | Mar 04 1988 | Blood glucose level sensing | |
| 4858615, | Nov 10 1981 | Sentron v.o.f. | Catheter sensor and memory unit |
| 4861830, | Feb 29 1980 | TC1 LLC | Polymer systems suitable for blood-contacting surfaces of a biomedical device, and methods for forming |
| 4871440, | Jul 06 1987 | SANKYO COMPANY LTD | Biosensor |
| 4883057, | May 09 1984 | Research Foundation, The City University of New York | Cathodic electrochemical current arrangement with telemetric application |
| 4886740, | Jun 05 1985 | VICTORIA UNIVERSITY OF MANCHESTER, THE | Enzyme-electrode sensor with organosilane treated membrane |
| 4890620, | Sep 20 1985 | The Regents of the University of California | Two-dimensional diffusion glucose substrate sensing electrode |
| 4890621, | Jan 19 1988 | Northstar Research Institute, Ltd. | Continuous glucose monitoring and a system utilized therefor |
| 4909908, | Apr 24 1986 | Electrochemical cncentration detector method | |
| 4919141, | Jan 03 1987 | INSTITUT FUR DIABETESTECHNOLOGIE GEMEINNUTZIGE FORSCHUNGS - UND ENTWICKLUNGSGESELLSCHAFT MBH | Implantable electrochemical sensor |
| 4927407, | Jun 19 1989 | REGENTS OF THE UNIVERSITY OF MINNESOTA, A CORP OF MN | Cardiac assist pump with steady rate supply of fluid lubricant |
| 4953552, | Apr 21 1989 | Blood glucose monitoring system | |
| 4955861, | Apr 21 1988 | Therex Limited Partnership | Dual access infusion and monitoring system |
| 4970145, | May 27 1986 | Cambridge Life Sciences PLC | Immobilized enzyme electrodes |
| 4973320, | Aug 04 1987 | Firma Carl Freudenberg | Tissue-compatible medical device and method for manufacturing the same |
| 4974929, | Sep 22 1987 | Baxter International, Inc. | Fiber optical probe connector for physiologic measurement devices |
| 4975175, | Mar 27 1987 | Isao, Karube; Fujitsu Limited | Miniaturized oxygen electrode and miniaturized biosensor and production process thereof |
| 4992794, | Oct 10 1989 | Texas Instruments Incorporated | Transponder and method for the production thereof |
| 4994167, | Sep 10 1985 | DEXCOM, INC | Biological fluid measuring device |
| 5030333, | Sep 13 1984 | Children's Hospital Medical Center | Polarographic method for measuring both analyte and oxygen with the same detecting electrode of an electroenzymatic sensor |
| 5034112, | May 19 1988 | NISSAN MOTOR CO , LTD | Device for measuring concentration of nitrogen oxide in combustion gas |
| 5050612, | Sep 12 1989 | Device for computer-assisted monitoring of the body | |
| 5063081, | Nov 14 1988 | I-Stat Corporation | Method of manufacturing a plurality of uniform microfabricated sensing devices having an immobilized ligand receptor |
| 5089112, | Mar 20 1989 | Brookhaven Science Associates | Electrochemical biosensor based on immobilized enzymes and redox polymers |
| 5140985, | Aug 01 1991 | Noninvasive blood glucose measuring device | |
| 5155149, | Oct 10 1991 | BECTON DICKINSON CRITICAL CARE SYSTEMS PTE LTD | Silicone polyurethane copolymers containing oxygen sensitive phosphorescent dye compounds |
| 5165407, | Apr 19 1990 | UNIVERSITY OF KANSAS, THE, | Implantable glucose sensor |
| 5171689, | Nov 08 1984 | MATSUSHITA ELECTRIC INDUSTRIAL CO , LTD | Solid state bio-sensor |
| 5183549, | Jan 26 1990 | CommTech International Management Corporation | Multi-analyte sensing electrolytic cell |
| 5190041, | Aug 11 1989 | CB-CARMEL BIOTECHNOLOGY LTD | System for monitoring and controlling blood glucose |
| 5198771, | Sep 03 1991 | TRANSDUCER RESEARCH, INC OF MINNESOTA | Potentiostatic apparatus and methods |
| 5200051, | Nov 14 1988 | I-Stat Corporation | Wholly microfabricated biosensors and process for the manufacture and use thereof |
| 5202261, | Jul 19 1990 | Miles Inc. | Conductive sensors and their use in diagnostic assays |
| 5212050, | Nov 14 1988 | I-STAT CORPORATION, A DE CORP | Method of forming a permselective layer |
| 5242835, | Nov 03 1987 | Radiometer A/S | Method and apparatus for determining the concentration of oxygen |
| 5249576, | Oct 24 1991 | Datex-Ohmeda, Inc | Universal pulse oximeter probe |
| 5250439, | Nov 18 1991 | Miles Inc. | Use of conductive sensors in diagnostic assays |
| 5266179, | Jul 20 1990 | Matsushita Electric Industrial Co., Ltd.; Kyoto Daiichi Kagaku Co., Ltd. | Quantitative analysis method and its system using a disposable sensor |
| 5281319, | Jul 09 1991 | Agency of Industrial Science and Technology | Carbon micro-sensor electrode and method for preparing it |
| 5282848, | Aug 28 1990 | Maquet Cardiovascular, LLC | Self-supporting woven vascular graft |
| 5284140, | Feb 11 1992 | Disetronic Licensing AG | Acrylic copolymer membranes for biosensors |
| 5286364, | Dec 20 1989 | YACYNYCH, ALEXANDER M | Surface-modified electochemical biosensor |
| 5298144, | Sep 15 1992 | YSI, INCORPORATED | Chemically wired fructose dehydrogenase electrodes |
| 5299571, | Jan 22 1993 | Disetronic Licensing AG | Apparatus and method for implantation of sensors |
| 5307263, | Nov 17 1992 | HEALTH HERO NETWORK, INC | Modular microprocessor-based health monitoring system |
| 5310469, | Dec 31 1991 | HOSPIRA, INC | Biosensor with a membrane containing biologically active material |
| 5312361, | Sep 13 1991 | Automatic cannulation device | |
| 5322063, | Oct 04 1991 | Disetronic Licensing AG | Hydrophilic polyurethane membranes for electrochemical glucose sensors |
| 5330634, | Aug 28 1992 | SEGARS CALIFORNIA PARTNERS, LP | Calibration solutions useful for analyses of biological fluids and methods employing same |
| 5337747, | Oct 06 1989 | Implantable device for estimating glucose levels | |
| 5352348, | Apr 09 1987 | Nova Biomedical Corporation | Method of using enzyme electrode |
| 5352351, | Jun 08 1993 | Roche Diabetes Care, Inc | Biosensing meter with fail/safe procedures to prevent erroneous indications |
| 5354449, | Jan 02 1992 | Monitoring Technology Limited | pH electrode |
| 5372133, | Feb 05 1992 | N.V. Nederlandsche Apparatenfabriek NEDAP | Implantable biomedical sensor device, suitable in particular for measuring the concentration of glucose |
| 5384028, | Aug 28 1992 | NEC Corporation | Biosensor with a data memory |
| 5387327, | Oct 19 1992 | Duquesne University of the Holy Ghost | Implantable non-enzymatic electrochemical glucose sensor |
| 5390671, | Mar 15 1994 | MEDTRONIC MINIMED, INC | Transcutaneous sensor insertion set |
| 5391250, | Mar 15 1994 | MEDTRONIC MINIMED, INC | Method of fabricating thin film sensors |
| 5411647, | Nov 23 1992 | Disetronic Licensing AG | Techniques to improve the performance of electrochemical sensors |
| 5411866, | Mar 30 1993 | National Research Council of Canada | Method and system for determining bioactive substances |
| 5425717, | May 07 1993 | Becton, Dickinson and Company | Epidural catheter system utilizing splittable needle |
| 5428123, | Apr 24 1992 | POLYMER TECHNOLOGY GROUP, THE | Copolymers and non-porous, semi-permeable membrane thereof and its use for permeating molecules of predetermined molecular weight range |
| 5431160, | Jul 19 1989 | University of New Mexico | Miniature implantable refillable glucose sensor and material therefor |
| 5438984, | Sep 08 1988 | SUDORMED, INC | Apparatus and method for the collection of analytes on a dermal patch |
| 5462645, | Sep 20 1991 | Imperial College of Science, Technology & Medicine | Dialysis electrode device |
| 5466575, | Nov 14 1988 | I-Stat Corporation | Process for the manufacture of wholly microfabricated biosensors |
| 5469846, | Oct 19 1992 | Duquesne University of the Holy Ghost | Implantable non-enzymatic electrochemical glucose sensor |
| 5474552, | Jun 27 1994 | CB-Carmel Biotechnology Ltd. | Implantable drug delivery pump |
| 5476094, | Feb 11 1992 | Disetronic Licensing AG | Acrylic copolymer membranes for biosensors |
| 5476776, | Jul 19 1989 | University of New Mexico | Immobilized enzymes for use in an electrochemical sensor |
| 5482008, | Sep 13 1991 | Electronic animal identification system | |
| 5482473, | May 09 1994 | MEDTRONIC MINIMED, INC | Flex circuit connector |
| 5486776, | Sep 29 1994 | XILINX, Inc.; Xilinx, Inc | Antifuse-based programmable logic circuit |
| 5494562, | Jun 27 1994 | Siemens Healthcare Diagnostics Inc | Electrochemical sensors |
| 5496453, | May 17 1991 | Kyoto Daiichi Kagaku Co., Ltd. | Biosensor and method of quantitative analysis using the same |
| 5497772, | Nov 19 1993 | MANN, ALFRED E , FOUNDATION FOR SCIENTIFIC RESEARCH | Glucose monitoring system |
| 5502396, | Sep 21 1993 | Asulab S.A. | Measuring device with connection for a removable sensor |
| 5507288, | May 05 1994 | Boehringer Mannheim GmbH | Analytical system for monitoring a substance to be analyzed in patient-blood |
| 5508509, | Nov 30 1993 | Terumo Cardiovascular Systems Corporation | Sensing elements and methods for uniformly making individual sensing elements |
| 5531878, | May 13 1993 | The Victoria University of Manchester | Sensor devices |
| 5564439, | May 13 1991 | George J., Picha | Infusion device for soft tissue |
| 5568806, | Feb 16 1995 | MEDTRONIC MINIMED, INC | Transcutaneous sensor insertion set |
| 5569186, | Apr 25 1994 | MEDTRONIC MINIMED, INC | Closed loop infusion pump system with removable glucose sensor |
| 5569462, | Sep 24 1993 | Baxter International Inc. | Methods for enhancing vascularization of implant devices |
| 5571395, | Nov 04 1993 | GOLDSTAR CO , LTD | Breath alcohol analyzer using a biosensor |
| 5575930, | Oct 07 1992 | Ecossensors Limited | Method of making gas permeable membranes for amperometric gas electrodes |
| 5582184, | Oct 13 1993 | Integ Incorporated | Interstitial fluid collection and constituent measurement |
| 5582497, | Jan 29 1992 | Wing Labo Co., Ltd. | Automatic warehouse system |
| 5593852, | Dec 02 1993 | Abbott Diabetes Care Inc | Subcutaneous glucose electrode |
| 5605152, | Jul 18 1994 | MEDTRONIC MINIMED, INC | Optical glucose sensor |
| 5607565, | Mar 27 1995 | COULTER INTERNATIONAL CORP | Apparatus for measuring analytes in a fluid sample |
| 5611900, | Jul 20 1995 | Michigan State University | Microbiosensor used in-situ |
| 5624537, | Sep 20 1994 | BRITISH COLUMBIA, UNIVERSITY OF, THE | Biosensor and interface membrane |
| 5628890, | Sep 27 1995 | MEDISENSE, INC | Electrochemical sensor |
| 5640954, | May 05 1995 | INSTITUT FUER DIABETES-TECHNOLOGIE GEMEINNUETZIGE FORSCHUNGS- UND ENTWICKLUNGSGESELLSCHAFT MBH AN DER UNIVERSITAET ULM | Method and apparatus for continuously monitoring the concentration of a metabolyte |
| 5653863, | May 05 1995 | Bayer HealthCare LLC | Method for reducing bias in amperometric sensors |
| 5660163, | Nov 19 1993 | Alfred E. Mann Foundation for Scientific Research | Glucose sensor assembly |
| 5665222, | Oct 11 1995 | THERASENSE, INC | Soybean peroxidase electrochemical sensor |
| 5676820, | Feb 03 1995 | NEW MEXICO STATE UNIVERSITY - TECHNOLOGY TRANSFER CORPORATION | Remote electrochemical sensor |
| 5682884, | May 05 1983 | MediSense, Inc. | Strip electrode with screen printing |
| 5686829, | Jun 03 1994 | Metrohm AG | Voltammetric method and apparatus |
| 5703359, | Jul 29 1996 | Inficon GmbH | Composite membrane and support assembly |
| 5704354, | Jun 23 1994 | Siemens Aktiengesellschaft | Electrocatalytic glucose sensor |
| 5706807, | May 13 1991 | Applied Medical Research | Sensor device covered with foam membrane |
| 5707502, | Jul 12 1996 | Siemens Healthcare Diagnostics Inc | Sensors for measuring analyte concentrations and methods of making same |
| 5711861, | Nov 22 1995 | Legacy Good Samaritan Hospital and Medical Center | Device for monitoring changes in analyte concentration |
| 5735273, | Sep 12 1995 | Animas Technologies LLC | Chemical signal-impermeable mask |
| 5741330, | Oct 31 1990 | Baxalta GmbH | Close vascularization implant material |
| 5741634, | Aug 03 1993 | A & D Company Limited | Throwaway type chemical sensor |
| 5746898, | Aug 10 1990 | Siemens Aktiengesellschaft | Electrochemical-enzymatic sensor |
| 5749832, | Feb 01 1992 | Queen Mary and Westfield College, University of London | Monitoring systems |
| 5756632, | Apr 24 1992 | The Polymer Technology Group | Systems for premeating molecules of predetermined molecular weight range |
| 5776324, | May 17 1996 | PIONEER SURGICAL TECHNOLOGY, INC | Electrochemical biosensors |
| 5777060, | Mar 27 1995 | MINIMED, INC | Silicon-containing biocompatible membranes |
| 5791344, | Nov 19 1993 | ALFRED E MANN FOUNDATION FOR SCIENTIFIC RESEARCH | Patient monitoring system |
| 5795453, | Jan 23 1996 | Electrodes and metallo isoindole ringed compounds | |
| 5795774, | Jul 10 1996 | NEC Corporation | Biosensor |
| 5800420, | Nov 04 1994 | Elan Corporation, PLC | Analyte-controlled liquid delivery device and analyte monitor |
| 5807375, | Nov 04 1994 | Elan Corporation, PLC | Analyte-controlled liquid delivery device and analyte monitor |
| 5820622, | Nov 04 1994 | Elan Pharma International Limited | Analyte-controlled liquid delivery device and analyte monitor |
| 5833603, | Mar 13 1996 | Allergan, Inc | Implantable biosensing transponder |
| 5837454, | Nov 14 1988 | I-Stat Corporation | Process for the manufacture of wholly microfabricated biosensors |
| 5840148, | Jun 30 1995 | BIO MEDIC DATA SYSTEMS, INC | Method of assembly of implantable transponder |
| 5851197, | Feb 05 1997 | MEDTRONIC MINIMED, INC | Injector for a subcutaneous infusion set |
| 5863400, | Apr 14 1994 | Lifescan, Inc | Electrochemical cells |
| 5879373, | Dec 24 1994 | Roche Diagnostics GmbH | System and method for the determination of tissue properties |
| 5882494, | Mar 27 1995 | MiniMed, Inc. | Polyurethane/polyurea compositions containing silicone for biosensor membranes |
| 5895235, | Apr 12 1995 | EM Microelectronic-Marin SA | Process for manufacturing transponders of small dimensions |
| 5914026, | Jan 06 1997 | TENAX THERAPEUTICS, INC | Implantable sensor employing an auxiliary electrode |
| 5928130, | Mar 16 1998 | Apparatus and method for implanting radioactive seeds in tissue | |
| 5944661, | Apr 16 1997 | GINER, INC. | Potential and diffusion controlled solid electrolyte sensor for continuous measurement of very low levels of transdermal alcohol |
| 5954643, | Jun 09 1997 | MEDTRONIC MINIMED, INC | Insertion set for a transcutaneous sensor |
| 5954954, | Oct 16 1992 | TELEDYNE ISCO, INC | Method and apparatus for determination of analyte concentration |
| 5957854, | Sep 04 1993 | Body Science LLC | Wireless medical diagnosis and monitoring equipment |
| 5963132, | Oct 11 1996 | Avid Indentification Systems, Inc.; AVID MARKETING, INC | Encapsulated implantable transponder |
| 5964993, | Dec 19 1996 | TENAX THERAPEUTICS, INC | Glucose sensor |
| 5965380, | Dec 02 1993 | THERASENSE, INC | Subcutaneous glucose electrode |
| 5972199, | Oct 11 1995 | Abbott Diabetes Care Inc | Electrochemical analyte sensors using thermostable peroxidase |
| 5985129, | Dec 14 1989 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE A CORPORATION OF CA | Method for increasing the service life of an implantable sensor |
| 5989409, | Sep 11 1995 | Animas Technologies LLC | Method for glucose sensing |
| 5999848, | Sep 12 1997 | ALFRED E MANN FOUNDATION | Daisy chainable sensors and stimulators for implantation in living tissue |
| 6001067, | Mar 04 1997 | DEXCOM, INC | Device and method for determining analyte levels |
| 6011984, | Nov 22 1995 | MEDTRONIC MINIMED, INC | Detection of biological molecules using chemical amplification and optical sensors |
| 6013113, | Mar 06 1998 | GREATBATCH, LTD NEW YORK CORPORATION | Slotted insulator for unsealed electrode edges in electrochemical cells |
| 6030827, | Jan 23 1998 | ABBOTT POINT OF CARE INC | Microfabricated aperture-based sensor |
| 6049727, | Apr 03 1998 | Animas Corporation | Implantable sensor and system for in vivo measurement and control of fluid constituent levels |
| 6051389, | Nov 14 1996 | RADIOMETER MEDICAL APS | Enzyme sensor |
| 6059946, | Apr 14 1997 | PHC HOLDINGS CO , LTD ; PANASONIC HEALTHCARE HOLDINGS CO , LTD | Biosensor |
| 6066083, | Nov 27 1998 | Syntheon, LLC | Implantable brachytherapy device having at least partial deactivation capability |
| 6066448, | Mar 10 1995 | MESO SCALE TECHNOLOGIES, INC | Multi-array, multi-specific electrochemiluminescence testing |
| 6081735, | Oct 06 1993 | JPMorgan Chase Bank, National Association | Signal processing apparatus |
| 6081736, | Oct 20 1997 | ALFRED E, MANN FOUNDATION | Implantable enzyme-based monitoring systems adapted for long term use |
| 6083710, | Dec 02 1993 | THERASENSE, INC | Electrochemical analyte measurement system |
| 6088608, | Oct 20 1997 | ALFRED E MANN FOUNDATION | Electrochemical sensor and integrity tests therefor |
| 6093156, | Dec 06 1996 | Abbott Laboratories | Method and apparatus for obtaining blood for diagnostic tests |
| 6093172, | Feb 05 1997 | MEDTRONIC MINIMED, INC | Injector for a subcutaneous insertion set |
| 6117290, | Sep 26 1997 | Pepex Biomedical, LLC | System and method for measuring a bioanalyte such as lactate |
| 6119028, | Oct 20 1997 | ALFRED E MANN FOUNDATION | Implantable enzyme-based monitoring systems having improved longevity due to improved exterior surfaces |
| 6120676, | Feb 06 1997 | THERASENSE, INC | Method of using a small volume in vitro analyte sensor |
| 6121009, | Dec 02 1993 | THERASENSE, INC | Electrochemical analyte measurement system |
| 6122536, | Jul 06 1995 | Animas Corporation | Implantable sensor and system for measurement and control of blood constituent levels |
| 6134461, | Mar 04 1998 | Abbott Diabetes Care Inc | Electrochemical analyte |
| 6141573, | Sep 12 1995 | Animas Technologies LLC | Chemical signal-impermeable mask |
| 6144869, | May 13 1998 | Lifescan IP Holdings, LLC | Monitoring of physiological analytes |
| 6144871, | Mar 31 1998 | NEC Corporation | Current detecting sensor and method of fabricating the same |
| 6162611, | Dec 02 1993 | THERASENSE, INC | Subcutaneous glucose electrode |
| 6175752, | Apr 30 1998 | Abbott Diabetes Care Inc | Analyte monitoring device and methods of use |
| 6189536, | Apr 15 1999 | Medtronic, Inc | Method for protecting implantable devices |
| 6212416, | Nov 22 1995 | Legacy Good Samaritan Hospital and Medical Center | Device for monitoring changes in analyte concentration |
| 6233471, | May 13 1998 | Lifescan IP Holdings, LLC | Signal processing for measurement of physiological analysis |
| 6248067, | Feb 05 1999 | MEDTRONIC MINIMED, INC | Analyte sensor and holter-type monitor system and method of using the same |
| 6256522, | Nov 23 1992 | University of Pittsburgh of the Commonwealth System of Higher Education | Sensors for continuous monitoring of biochemicals and related method |
| 6259937, | Sep 12 1997 | AFRED E MANN FOUNDATION FOR SCIENTIFIC RESEARCH | Implantable substrate sensor |
| 6264825, | Jun 23 1998 | CLINICAL MICRO SENSORS, INC , DBA OSMETECH TECHNOLOGY INC | Binding acceleration techniques for the detection of analytes |
| 6268161, | Sep 30 1997 | M-Biotech, Inc. | Biosensor |
| 6274285, | Nov 11 1919 | AGFA-GEVAERT NV | Radiation-sensitive recording material for the production of driographic offset printing plates |
| 6275717, | Jun 16 1997 | Alkermes Pharma Ireland Limited | Device and method of calibrating and testing a sensor for in vivo measurement of an analyte |
| 6284478, | Dec 02 1993 | Abbott Diabetes Care Inc | Subcutaneous glucose electrode |
| 6285897, | Apr 07 1999 | Given Imaging LTD | Remote physiological monitoring system |
| 6293925, | Dec 31 1997 | MEDTRONIC MINIMED, INC | Insertion device for an insertion set and method of using the same |
| 6294281, | Jun 17 1998 | Abbott Diabetes Care Inc | Biological fuel cell and method |
| 6300002, | May 13 1999 | Moltech Power Systems, Inc | Notched electrode and method of making same |
| 6309526, | Jul 10 1997 | PHC HOLDINGS CO , LTD ; PANASONIC HEALTHCARE HOLDINGS CO , LTD | Biosensor |
| 6325979, | Oct 15 1996 | Robert Bosch GmbH | Device for gas-sensoring electrodes |
| 6329161, | Dec 02 1993 | Abbott Diabetes Care Inc | Subcutaneous glucose electrode |
| 6343225, | Sep 14 1999 | ARBMETRICS LLC | Implantable glucose sensor |
| 6356776, | May 13 1998 | Lifescan IP Holdings, LLC | Device for monitoring of physiological analytes |
| 6360888, | Feb 25 1999 | MEDTRONIC MINIMED, INC | Glucose sensor package system |
| 6366794, | Nov 20 1998 | University of Connecticut, The; PRECISION CONTROL DESIGN, INC | Generic integrated implantable potentiostat telemetry unit for electrochemical sensors |
| 6368141, | Jun 09 1997 | MEDTRONIC MINIMED, INC | Insertion set for a transcutenous sensor with cable connector lock mechanism |
| 6368274, | Jul 01 1999 | MEDTRONIC MINIMED, INC | Reusable analyte sensor site and method of using the same |
| 6400974, | Jun 29 2000 | Senseonics, Incorporated | Implanted sensor processing system and method for processing implanted sensor output |
| 6407195, | Apr 25 1996 | 3M INNOVATIVE PROLPERTIES COMPANY | Tackified polydiorganosiloxane oligourea segmented copolymers and a process for making same |
| 6409674, | Sep 24 1998 | Pacesetter, Inc | Implantable sensor with wireless communication |
| 6413393, | Jul 07 1999 | MEDTRONIC MINIMED, INC | Sensor including UV-absorbing polymer and method of manufacture |
| 6418332, | Feb 25 1999 | MEDTRONIC MINIMED, INC | Test plug and cable for a glucose monitor |
| 6424847, | Feb 25 1999 | MEDTRONIC MINIMED, INC | Glucose monitor calibration methods |
| 6442413, | May 15 2000 | Implantable sensor | |
| 6447448, | Dec 31 1998 | BALL SEMICONDUCTOR, INC | Miniature implanted orthopedic sensors |
| 6454710, | Apr 11 2001 | Cilag GmbH International; Lifescan IP Holdings, LLC | Devices and methods for monitoring an analyte |
| 6459917, | May 22 2000 | Apparatus for access to interstitial fluid, blood, or blood plasma components | |
| 6461496, | Oct 08 1998 | Abbott Diabetes Care Inc | Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator |
| 6466810, | Nov 22 1995 | Legacy Good Samaritan Hospital and Medical Center | Implantable device for monitoring changes in analyte concentration |
| 6484045, | Feb 10 2000 | MEDTRONIC MINIMED, INC | Analyte sensor and method of making the same |
| 6484046, | Mar 04 1998 | Abbott Diabetes Care Inc | Electrochemical analyte sensor |
| 6498941, | Mar 09 2000 | Advanced Cardiovascular Systems, Inc.; Advanced Cardiovascular Systems, INC | Catheter based probe and method of using same for detecting chemical analytes |
| 6510329, | Jan 24 2001 | Datex-Ohmeda, Inc.; Datex-Ohmeda, Inc | Detection of sensor off conditions in a pulse oximeter |
| 6512939, | Oct 20 1997 | Medtronic MiniMed, Inc. | Implantable enzyme-based monitoring systems adapted for long term use |
| 6514718, | Mar 04 1991 | TheraSense, Inc. | Subcutaneous glucose electrode |
| 6520326, | Feb 25 1999 | Medtronic MiniMed, Inc. | Glucose sensor package system |
| 6534711, | Apr 14 1998 | The Goodyear Tire & Rubber Company | Encapsulation package and method of packaging an electronic circuit module |
| 6542765, | Jan 29 1988 | The Regent of the University of California | Method for the iontophoretic non-invasive determination of the in vivo concentration level of an inorganic or organic substance |
| 6546268, | Jun 02 1999 | BALL SEMICONDUCTOR, INC | Glucose sensor |
| 6547839, | Jan 23 2001 | SKC CO , LTD | Method of making an electrochemical cell by the application of polysiloxane onto at least one of the cell components |
| 6551496, | Mar 03 2000 | YSI Incorporated | Microstructured bilateral sensor |
| 6553241, | Aug 31 2000 | Covidien LP | Oximeter sensor with digital memory encoding sensor expiration data |
| 6558320, | Jan 20 2000 | MEDTRONIC MINIMED, INC | Handheld personal data assistant (PDA) with a medical device and method of using the same |
| 6558321, | Mar 04 1997 | DEXCOM INC | Systems and methods for remote monitoring and modulation of medical devices |
| 6558351, | Jun 03 1999 | MEDTRONIC MINIMED, INC | Closed loop system for controlling insulin infusion |
| 6560471, | Jan 02 2001 | Abbott Diabetes Care Inc | Analyte monitoring device and methods of use |
| 6565509, | Apr 30 1998 | Abbott Diabetes Care Inc | Analyte monitoring device and methods of use |
| 6579498, | Mar 20 1998 | Implantable blood glucose sensor system | |
| 6595919, | May 13 1998 | Lifescan IP Holdings, LLC | Device for signal processing for measurement of physiological analytes |
| 6612984, | Dec 03 1999 | System and method for collecting and transmitting medical data | |
| 6613379, | May 08 2001 | KONAMITE LIMITED | Implantable analyte sensor |
| 6615078, | Apr 22 1999 | Lifescan IP Holdings, LLC | Methods and devices for removing interfering species |
| 6618934, | Oct 08 1998 | Abbott Diabetes Care Inc | Method of manufacturing small volume in vitro analyte sensor |
| 6642015, | Dec 29 2000 | MINIMED INC | Hydrophilic polymeric material for coating biosensors |
| 6654625, | Jun 18 1999 | Abbott Diabetes Care Inc | Mass transport limited in vivo analyte sensor |
| 6689265, | Oct 11 1995 | Abbott Diabetes Care Inc | Electrochemical analyte sensors using thermostable soybean peroxidase |
| 6699383, | Nov 25 1999 | Vitesco Technologies GMBH | Method for determining a NOx concentration |
| 6702857, | Jul 27 2001 | DEXCOM, INC | Membrane for use with implantable devices |
| 6721587, | Feb 15 2001 | Regents of the University of California, The | Membrane and electrode structure for implantable sensor |
| 6730200, | Jun 18 1999 | Abbott Laboratories | Electrochemical sensor for analysis of liquid samples |
| 6737158, | Oct 30 2002 | W L GORE & ASSOCIATES, INC | Porous polymeric membrane toughened composites |
| 6741877, | Mar 04 1997 | DEXCOM, INC | Device and method for determining analyte levels |
| 6743635, | Apr 25 2002 | TRIVIDIA HEALTH, INC | System and methods for blood glucose sensing |
| 6773565, | Jun 22 2000 | Kabushiki Kaisha Riken | NOx sensor |
| 6784274, | Oct 24 1996 | MiniMed Inc. | Hydrophilic, swellable coatings for biosensors |
| 6793802, | Jan 04 2001 | TYSON BIORESEARCH, INC | Biosensors having improved sample application and measuring properties and uses thereof |
| 6801041, | May 14 2002 | Abbott Laboratories | Sensor having electrode for determining the rate of flow of a fluid |
| 6802957, | Sep 28 2001 | Marine Biological Laboratory | Self-referencing enzyme-based microsensor and method of use |
| 6809507, | Oct 23 2001 | MEDTRONIC MINIMED, INC | Implantable sensor electrodes and electronic circuitry |
| 6809653, | Oct 08 1998 | MEDTRONIC MINIMED, INC | Telemetered characteristic monitor system and method of using the same |
| 6862465, | Mar 04 1997 | DEXCOM, INC | Device and method for determining analyte levels |
| 6881551, | Mar 04 1991 | TheraSense, Inc. | Subcutaneous glucose electrode |
| 6891317, | May 22 2001 | SRI International | Rolled electroactive polymers |
| 6892085, | Feb 25 1999 | Medtronic MiniMed, Inc. | Glucose sensor package system |
| 6893552, | Dec 29 1997 | ARROWHEAD CENTER, INC | Microsensors for glucose and insulin monitoring |
| 6895263, | Feb 23 2000 | Medtronic MiniMed, Inc. | Real time self-adjusting calibration algorithm |
| 6895265, | May 15 2000 | Implantable sensor | |
| 6952604, | Dec 21 2001 | Becton, Dickinson and Company | Minimally-invasive system and method for monitoring analyte levels |
| 6965791, | Mar 26 2003 | SORENSON DEVELOPMENT, INCORPORATED | Implantable biosensor system, apparatus and method |
| 6972080, | Jun 10 1999 | MATSUSHITA ELECTRIC INDUSTRIAL CO , LTD | Electrochemical device for moving particles covered with protein |
| 7003336, | Feb 10 2000 | MEDTRONIC MINIMED, INC | Analyte sensor method of making the same |
| 7008979, | Apr 30 2002 | Hydromer, Inc. | Coating composition for multiple hydrophilic applications |
| 7033322, | May 15 2000 | Implantable sensor | |
| 7070580, | Apr 01 2003 | UNOMEDICAL A S | Infusion device and an adhesive sheet material and a release liner |
| 7078582, | Jan 17 2001 | 3M Innovative Properties Company | Stretch removable adhesive articles and methods |
| 7081195, | Dec 08 2003 | DEXCOM, INC | Systems and methods for improving electrochemical analyte sensors |
| 7110803, | Mar 04 1997 | DexCom, Inc. | Device and method for determining analyte levels |
| 7115884, | Oct 06 1997 | Trustees of Tufts College | Self-encoding fiber optic sensor |
| 7134999, | Apr 04 2003 | DEXCOM, INC | Optimized sensor geometry for an implantable glucose sensor |
| 7136689, | Mar 04 1997 | DexCom, Inc. | Device and method for determining analyte levels |
| 7153265, | Apr 22 2002 | Medtronic MiniMed, Inc. | Anti-inflammatory biosensor for reduced biofouling and enhanced sensor performance |
| 7166074, | Jul 01 1999 | Medtronic MiniMed, Inc. | Reusable analyte sensor site and method of using the same |
| 7192450, | May 21 2003 | DEXCOM, INC | Porous membranes for use with implantable devices |
| 7207974, | Feb 05 1997 | Medtronic MiniMed, Inc. | Insertion device for an insertion set and method of using the same |
| 7248906, | Dec 17 2001 | P&V CONSULTING GMBH & CO KG | Method and device for monitoring analyte concentration by optical detection |
| 7267665, | Jun 03 1999 | MEDTRONIC MINIMED, INC | Closed loop system for controlling insulin infusion |
| 7279174, | May 08 2003 | Advanced Cardiovascular Systems, Inc. | Stent coatings comprising hydrophilic additives |
| 20020042561, | |||
| 20020084196, | |||
| 20020099997, | |||
| 20020119711, | |||
| 20020177763, | |||
| 20020188185, | |||
| 20030004457, | |||
| 20030006669, | |||
| 20030009093, | |||
| 20030032874, | |||
| 20030036773, | |||
| 20030050546, | |||
| 20030065254, | |||
| 20030088166, | |||
| 20030097082, | |||
| 20030125613, | |||
| 20030130616, | |||
| 20030134347, | |||
| 20030138674, | |||
| 20030187338, | |||
| 20030199745, | |||
| 20030203498, | |||
| 20030211050, | |||
| 20030211625, | |||
| 20030225324, | |||
| 20030225437, | |||
| 20030235817, | |||
| 20040006263, | |||
| 20040015063, | |||
| 20040045879, | |||
| 20040063167, | |||
| 20040074785, | |||
| 20040078219, | |||
| 20040106857, | |||
| 20040106859, | |||
| 20040111017, | |||
| 20040133164, | |||
| 20040138543, | |||
| 20040143173, | |||
| 20040167801, | |||
| 20040173472, | |||
| 20040176672, | |||
| 20040180391, | |||
| 20040219664, | |||
| 20040224001, | |||
| 20040234575, | |||
| 20040236200, | |||
| 20040242982, | |||
| 20040254433, | |||
| 20050027180, | |||
| 20050027181, | |||
| 20050027182, | |||
| 20050027463, | |||
| 20050031689, | |||
| 20050033132, | |||
| 20050038332, | |||
| 20050043598, | |||
| 20050051427, | |||
| 20050051440, | |||
| 20050054909, | |||
| 20050056551, | |||
| 20050056552, | |||
| 20050070770, | |||
| 20050077584, | |||
| 20050090607, | |||
| 20050096519, | |||
| 20050103625, | |||
| 20050112169, | |||
| 20050115832, | |||
| 20050121322, | |||
| 20050143635, | |||
| 20050176136, | |||
| 20050177036, | |||
| 20050181012, | |||
| 20050182451, | |||
| 20050183954, | |||
| 20050192557, | |||
| 20050197554, | |||
| 20050211571, | |||
| 20050215871, | |||
| 20050242479, | |||
| 20050245795, | |||
| 20050245799, | |||
| 20050258037, | |||
| 20050261563, | |||
| 20050272989, | |||
| 20060003398, | |||
| 20060015020, | |||
| 20060015024, | |||
| 20060016700, | |||
| 20060019327, | |||
| 20060020186, | |||
| 20060020187, | |||
| 20060020189, | |||
| 20060020191, | |||
| 20060020192, | |||
| 20060036139, | |||
| 20060036140, | |||
| 20060036141, | |||
| 20060036142, | |||
| 20060036143, | |||
| 20060036144, | |||
| 20060036145, | |||
| 20060078908, | |||
| 20060079740, | |||
| 20060142651, | |||
| 20060155180, | |||
| 20060177379, | |||
| 20060183871, | |||
| 20060183984, | |||
| 20060183985, | |||
| 20060189856, | |||
| 20060195029, | |||
| 20060198864, | |||
| 20060200019, | |||
| 20060200020, | |||
| 20060200022, | |||
| 20060200970, | |||
| 20060204536, | |||
| 20060211921, | |||
| 20060222566, | |||
| 20060224108, | |||
| 20060229512, | |||
| 20060235285, | |||
| 20060258761, | |||
| 20060263839, | |||
| 20060270922, | |||
| 20060270923, | |||
| 20060275857, | |||
| 20060275859, | |||
| 20060289307, | |||
| 20070007133, | |||
| 20070027384, | |||
| 20070027385, | |||
| 20070032717, | |||
| 20070032718, | |||
| 20070038044, | |||
| 20070045902, | |||
| 20070093704, | |||
| 20070135698, | |||
| 20070163880, | |||
| 20070173709, | |||
| 20070173710, | |||
| 20070173711, | |||
| 20070197889, | |||
| 20070203966, | |||
| 20070208246, | |||
| 20070213611, | |||
| 20070215491, | |||
| 20070218097, | |||
| 20070227907, | |||
| 20070232879, | |||
| 20070235331, | |||
| 20070259217, | |||
| 20070275193, | |||
| 20070299385, | |||
| 20080021666, | |||
| 20080027301, | |||
| 20080033269, | |||
| 20080034972, | |||
| 20080045824, | |||
| 20080154101, | |||
| 20080188731, | |||
| 20080194935, | |||
| 20080194938, | |||
| 20080208025, | |||
| 20080214915, | |||
| 20080214918, | |||
| 20080242961, | |||
| 20080262334, | |||
| 20080296155, | |||
| 20080306368, | |||
| 20090012379, | |||
| 20090045055, | |||
| 20090062633, | |||
| 20090076356, | |||
| 20090076360, | |||
| 20090099436, | |||
| 20090124879, | |||
| 20090143660, | |||
| EP98592, | |||
| EP127958, | |||
| EP284518, | |||
| EP320109, | |||
| EP353328, | |||
| EP390390, | |||
| EP396788, | |||
| EP476980, | |||
| EP534074, | |||
| EP535898, | |||
| EP539625, | |||
| EP817809, | |||
| EP838230, | |||
| EP967788, | |||
| EP1153571, | |||
| FR2656423, | |||
| FR2760962, | |||
| GB1442303, | |||
| JP2002189015, | |||
| JP2002913, | |||
| JP3293556, | |||
| JP62083649, | |||
| JP62083849, | |||
| JP63067560, | |||
| RE31916, | Apr 29 1981 | NATIONAL DRAEGER INC | Electrochemical detection cell |
| WO19887, | |||
| WO32098, | |||
| WO33065, | |||
| WO59373, | |||
| WO74753, | |||
| WO120019, | |||
| WO158348, | |||
| WO168901, | |||
| WO188524, | |||
| WO2053764, | |||
| WO2089666, | |||
| WO3011131, | |||
| WO2004021877, | |||
| WO2005012873, | |||
| WO2005026689, | |||
| WO2005045394, | |||
| WO2005057168, | |||
| WO2005057175, | |||
| WO2006017358, | |||
| WO2006018425, | |||
| WO2006105146, | |||
| WO2007114943, | |||
| WO8902720, | |||
| WO9007575, | |||
| WO9109302, | |||
| WO9207525, | |||
| WO9213271, | |||
| WO9314693, | |||
| WO9323744, | |||
| WO9422367, | |||
| WO9614026, | |||
| WO9625089, | |||
| WO9630431, | |||
| WO9701986, | |||
| WO9706727, | |||
| WO9819159, | |||
| WO9824358, | |||
| WO9838906, | |||
| WO9956613, | |||
| WO9958051, |
| Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
| Jan 03 2005 | SIMPSON, PETER C | DEXCOM, INC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 024693 | /0657 | |
| Jan 03 2005 | PETISCE, JAMES R | DEXCOM, INC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 024693 | /0657 | |
| Jan 07 2005 | BRAUKER, JAMES H | DEXCOM, INC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 024693 | /0657 | |
| Jan 11 2005 | CARR-BRENDEL, VICTORIA | DEXCOM, INC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 024693 | /0657 | |
| Jun 13 2008 | DexCom, Inc. | (assignment on the face of the patent) | / |
| Date | Maintenance Fee Events |
| Nov 20 2013 | ASPN: Payor Number Assigned. |
| Jan 13 2014 | M1552: Payment of Maintenance Fee, 8th Year, Large Entity. |
| Jan 11 2018 | M1553: Payment of Maintenance Fee, 12th Year, Large Entity. |
| Date | Maintenance Schedule |
| May 22 2015 | 4 years fee payment window open |
| Nov 22 2015 | 6 months grace period start (w surcharge) |
| May 22 2016 | patent expiry (for year 4) |
| May 22 2018 | 2 years to revive unintentionally abandoned end. (for year 4) |
| May 22 2019 | 8 years fee payment window open |
| Nov 22 2019 | 6 months grace period start (w surcharge) |
| May 22 2020 | patent expiry (for year 8) |
| May 22 2022 | 2 years to revive unintentionally abandoned end. (for year 8) |
| May 22 2023 | 12 years fee payment window open |
| Nov 22 2023 | 6 months grace period start (w surcharge) |
| May 22 2024 | patent expiry (for year 12) |
| May 22 2026 | 2 years to revive unintentionally abandoned end. (for year 12) |